<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/doi/10.1126/scitranslmed.abg7565');</script>

        <script> var body_html = '<body > <div > <div > <div > <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div ><a >Anywhere</a><a >Science</a><a >Science Advances</a><a >Science Immunology</a><a >Science Robotics</a><a >Science Signaling</a><a >Science Translational Medicine</a></div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > <a >covid-19</a> </li> <li > <a >climate</a> </li> <li > <a >science policy</a> </li> <li > <a >genome editing</a> </li> <li > <a >batteries</a> </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > <a >Current Issue</a> </li> <li > <a >First release papers</a> </li> <li > <a >Archive</a> </li> <li > <div > <a >About</a> <div > <a >About Science Translational Medicine</a> <a >Mission Scope</a> <a >Editors and Advisory Boards</a> <a >Editorial Policies</a> <a >Information for Authors</a> <a >Information for Reviewers</a> <a >Journal Metrics</a> <a >Staff</a> <a >Contact Us</a> <a >Subscribe</a> <a >Free Sample Articles</a> </div> </div> </li> </ul> </div> <div > <ul > <li > <a >Submit manuscript</a> </li> <li > <div > <a >More</a> </div> </li> </ul> </div> </div> <a >GET OUR E-ALERTS</a> </div></div></div> <main > <div ><div ><div ><div ><div > <div ><a >Home</a><a >Science Translational Medicine</a><a >Vol. 13, No. 625</a>An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</div><div >Back To Vol. 13, No. 625</div> </div> <article ><section ><header><div ><div ><div ><div >Research Article</div><div >CANCER</div></div><div ><div > <div >Share on</div> </div></div></div><h1 >An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h1><div >Paul-Joseph Aspuria https://orcid.org/0000-0002-3425-846X, Sandro Vivona https://orcid.org/0000-0003-2340-3219, Michele Bauer, Marie Semana, Navneet Ratti https://orcid.org/0000-0002-5203-8989, Scott McCauley https://orcid.org/0000-0003-4549-5599, Romina Riener https://orcid.org/0000-0001-5005-112X, … Show All … , Rene de Waal Malefyt https://orcid.org/0000-0002-2663-383X, Deepti Rokkam, Jan Emmerich https://orcid.org/0000-0002-7216-2231, Rob A. Kastelein https://orcid.org/0000-0001-5548-4696, Patrick J. Lupardus https://orcid.org/0000-0002-8662-074X, and Martin Oft https://orcid.org/0000-0001-9833-2326 [email protected] Show Fewer</div><div >Science Translational Medicine • 22 Dec 2021 • Vol 13, Issue 625 • DOI: 10.1126/scitranslmed.abg7565</div><div ><div > <div > <a ><div ><div ><h6>PREVIOUS ARTICLE</h6><div>A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</div></div></div>Previous</a><a ><div ><div ><h6>NEXT ARTICLE</h6><div>Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria</div></div></div>Next</a> </div> </div><div ><div >get access</div></div></div></div></header><div ><div ><section ><h2 >An orthogonal approach to cancer</h2><div >Interleukin-2 (IL-2) is an important cytokine for T cell activation and has been considered as a treatment for cancer. However, systemic administration of IL-2 often leads to severe toxicity. To address this, Zhang <i>et al.</i> and Aspuria <i>et al.</i> engineered T cells to express an IL-2 receptor β (IL-2Rβ) that can only be activated by a modified, orthogonal IL-2. Orthogonal IL-2Rβ was introduced to CAR T cells targeting CD19, and the CAR T cells were transferred to mice bearing leukemias or lymphomas. Administration of orthogonal IL-2 to CAR T cell recipients drove activation, expansion, and antitumor efficacy of CAR T cells in both preclinical models with limited systemic toxicity. Thus, orthogonal cytokine-receptor pairs may offer a safer approach to enhance adoptive cell therapy.</div></section><section ><h2 >Abstract</h2><div >Chimeric antigen receptor (CAR) T cells induce durable responses in patients with refractory hematological tumors. However, low CAR T cell activity, poor engraftment, or short in-patient persistence can lead to tumor progression or relapse. Furthermore, excessive CAR T cell expansion and activation can result in life-threatening cytokine release syndrome (CRS). Thus, in-patient control of the CAR T cell population is essential. Interleukin-2 (IL-2) is a critical cytokine for T cell proliferation and effector function, but its clinical use is limited by immune-mediated toxicity. Here, we report on an orthogonal IL-2 receptor and ligand system that enables specific in vivo control of CAR T cell expansion and activation, wherein an orthogonal human IL-2 (STK-009) selectively pairs with an orthogonal human IL-2Rβ (hoRb) expressed on CAR T cells. STK-009 expands hoRb-expressing CAR T cells in the presence and absence of tumor antigen and maintains the presence of stem cell memory T cells (T<sub>SCM</sub>) and effector T cells. In preclinical models of human CAR-refractory lymphoma, STK-009 treatment resulted in systemic and intratumoral expansion and activation of hoRb-expressing anti–CD19-CD28ζ CAR T cells (SYNCAR). The orthogonal IL-2 receptor/ligand system delivers complete responses in large subcutaneous lymphomas, even with substantially reduced CAR T cell doses, by selectively expanding and activating CAR T cells in vivo. STK-009 withdrawal allowed normal CAR T cell contraction, thereby limiting CRS induced by tumor antigen–specific T cell activation. These data suggest that the orthogonal IL-2 receptor/ligand system provides the in vivo control necessary to maximize efficacy of CAR T therapies.</div></section></div></div></section><section ><div ><div><div ><h5 >Get full access to this article</h5><p >View all available purchase options and get full access to this article.</p><div > Get Access</div><div >Already a Subscriber?Sign In</div></div></div></div></section><section ><div ><section ><h2>Supplementary Materials</h2><section ><h3>This PDF file includes:</h3><div ><div ><div>Figs. S1 to S7</div></div><div ><a >Download (1.50 MB)</a></div></div></section><section ><h3>Other Supplementary Material for this manuscript includes the following:</h3><div ><div ><div>Data file S1</div></div><div ><a >Download (83.48 KB)</a></div></div></section></section><div ><a >View/request a protocol for this paper from <i>Bio-protocol</i>.</a></div><section ><h2>References and Notes</h2><div ><div >1</div><div ><div ><div >S. S. Neelapu, F. L. Locke, N. L. Bartlett, L. J. Lekakis, D. B. Miklos, C. A. Jacobson, I. Braunschweig, O. O. Oluwole, T. Siddiqi, Y. Lin, J. M. Timmerman, P. J. Stiff, J. W. Friedberg, I. W. Flinn, A. Goy, B. T. Hill, M. R. Smith, A. Deol, U. Farooq, P. McSweeney, J. Munoz, I. Avivi, J. E. Castro, J. R. Westin, J. C. Chavez, A. Ghobadi, K. V. Komanduri, R. Levy, E. D. Jacobsen, T. E. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Y. Jiang, J. Aycock, M. Elias, D. Chang, J. Wiezorek, W. Y. Go, Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl. J. Med. <b>377</b>, 2531–2544 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >2</div><div ><div ><div >S. J. Schuster, M. R. Bishop, C. S. Tam, E. K. Waller, P. Borchmann, J. P. McGuirk, U. Jager, S. Jaglowski, C. Andreadis, J. R. Westin, I. Fleury, V. Bachanova, S. R. Foley, P. J. Ho, S. Mielke, J. M. Magenau, H. Holte, S. Pantano, L. B. Pacaud, R. Awasthi, J. Chu, O. Anak, G. Salles, R. T. Maziarz; JULIET Investigators, Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. <b>380</b>, 45–56 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >3</div><div ><div ><div >S. L. Maude, N. Frey, P. A. Shaw, R. Aplenc, D. M. Barrett, N. J. Bunin, A. Chew, V. E. Gonzalez, Z. Zheng, S. F. Lacey, Y. D. Mahnke, J. J. Melenhorst, S. R. Rheingold, A. Shen, D. T. Teachey, B. L. Levine, C. H. June, D. L. Porter, S. A. Grupp, Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. <b>371</b>, 1507–1517 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >4</div><div ><div ><div >M. Wang, J. Munoz, A. Goy, F. L. Locke, C. A. Jacobson, B. T. Hill, J. M. Timmerman, H. Holmes, S. Jaglowski, I. W. Flinn, P. A. McSweeney, D. B. Miklos, J. M. Pagel, M. J. Kersten, N. Milpied, H. Fung, M. S. Topp, R. Houot, A. Beitinjaneh, W. Peng, L. Zheng, J. M. Rossi, R. K. Jain, A. V. Rao, P. M. Reagan, KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. <b>382</b>, 1331–1342 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >5</div><div ><div ><div >C. H. June, R. S. O’Connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, CAR T cell immunotherapy for human cancer. Science <b>359</b>, 1361–1365 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >6</div><div ><div ><div >J. N. Kochenderfer, M. E. Dudley, S. A. Feldman, W. H. Wilson, D. E. Spaner, I. Maric, M. Stetler-Stevenson, G. Q. Phan, M. S. Hughes, R. M. Sherry, J. C. Yang, U. S. Kammula, L. Devillier, R. Carpenter, D. A. Nathan, R. A. Morgan, C. Laurencot, S. A. Rosenberg, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood <b>119</b>, 2709–2720 (2012).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >7</div><div ><div ><div >K. A. Hay, L. A. Hanafi, D. Li, J. Gust, W. C. Liles, M. M. Wurfel, J. A. Lopez, J. Chen, D. Chung, S. Harju-Baker, S. Cherian, X. Chen, S. R. Riddell, D. G. Maloney, C. J. Turtle, Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood <b>130</b>, 2295–2306 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >8</div><div ><div ><div >C. J. Turtle, L. A. Hanafi, C. Berger, T. A. Gooley, S. Cherian, M. Hudecek, D. Sommermeyer, K. Melville, B. Pender, T. M. Budiarto, E. Robinson, N. N. Steevens, C. Chaney, L. Soma, X. Chen, C. Yeung, B. Wood, D. Li, J. Cao, S. Heimfeld, M. C. Jensen, S. R. Riddell, D. G. Maloney, CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J. Clin. Invest. <b>126</b>, 2123–2138 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >9</div><div ><div ><div >M. B. Atkins, M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. A. Rosenberg, High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. <b>17</b>, 2105–2116 (1999).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >10</div><div ><div ><div >D. J. Peace, M. A. Cheever, Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. J. Exp. Med. <b>169</b>, 161–173 (1989).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >11</div><div ><div ><div >E. Assier, V. Jullien, J. Lefort, J. L. Moreau, J. P. Di Santo, B. B. Vargaftig, J. R. Lapa e Silva, J. Theze, NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J. Immunol. <b>172</b>, 7661–7668 (2004).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >12</div><div ><div ><div >J. T. Sockolosky, E. Trotta, G. Parisi, L. Picton, L. L. Su, A. C. Le, A. Chhabra, S. L. Silveria, B. M. George, I. C. King, M. R. Tiffany, K. Jude, L. V. Sibener, D. Baker, J. A. Shizuru, A. Ribas, J. A. Bluestone, K. C. Garcia, Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science <b>359</b>, 1037–1042 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >13</div><div ><div ><div >M. J. Grace, S. Lee, S. Bradshaw, J. Chapman, J. Spond, S. Cox, M. Delorenzo, D. Brassard, D. Wylie, S. Cannon-Carlson, C. Cullen, S. Indelicato, M. Voloch, R. Bordens, Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J. Biol. Chem. <b>280</b>, 6327–6336 (2005).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >14</div><div ><div ><div >P. A. Baeuerle, J. Ding, E. Patel, N. Thorausch, H. Horton, J. Gierut, I. Scarfo, R. Choudhary, O. Kiner, J. Krishnamurthy, B. Le, A. Morath, G. C. Baldeviano, J. Quinn, P. Tavares, Q. Wei, S. Weiler, M. V. Maus, D. Getts, W. W. Schamel, R. Hofmeister, Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response. Nat. Commun. <b>10</b>, 2087 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >15</div><div ><div ><div >J. S. Abramson, M. Lunning, M. L. Palomba, Chimeric antigen receptor T-cell therapies for aggressive B-cell lymphomas: Current and future state of the art. Am. Soc. Clin. Oncol. Educ. Book <b>39</b>, 446–453 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >16</div><div ><div ><div >M. A. Brehm, L. L. Kenney, M. V. Wiles, B. E. Low, R. M. Tisch, L. Burzenski, C. Mueller, D. L. Greiner, L. D. Shultz, Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB J. <b>33</b>, 3137–3151 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >17</div><div ><div ><div >U. Dafni, O. Michielin, S. M. Lluesma, Z. Tsourti, V. Polydoropoulou, D. Karlis, M. J. Besser, J. Haanen, I. M. Svane, P. S. Ohashi, U. S. Kammula, A. Orcurto, S. Zimmermann, L. Trueb, C. A. Klebanoff, M. T. Lotze, L. E. Kandalaft, G. Coukos, Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: A systematic review and meta-analysis. Ann. Oncol. <b>30</b>, 1902–1913 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >18</div><div ><div ><div >Q. Zhang, M. E. Hresko, L. K. Picton, L. Su, M. J. Hollander, S. Nunez-Cruz, Z. Zhang, C.-A. Assenmacher, J. T. Sockolosky, K. C. Garcia, M. C. Milone, A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci. Transl. Med. <b>625</b>, eabg6986 (2021).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >19</div><div ><div ><div >V. Kalia, S. Sarkar, S. Subramaniam, W. N. Haining, K. A. Smith, R. Ahmed, Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity <b>32</b>, 91–103 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >20</div><div ><div ><div >Y. Liu, N. Zhou, L. Zhou, J. Wang, Y. Zhou, T. Zhang, Y. Fang, J. Deng, Y. Gao, X. Liang, J. Lv, Z. Wang, J. Xie, Y. Xue, H. Zhang, J. Ma, K. Tang, Y. Fang, F. Cheng, C. Zhang, B. Dong, Y. Zhao, P. Yuan, Q. Gao, H. Zhang, F. Xiao-Feng Qin, B. Huang, IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor. Nat. Immunol. <b>22</b>, 358–369 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >21</div><div ><div ><div >M. E. Pipkin, J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, A. Rao, Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity <b>32</b>, 79–90 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >22</div><div ><div ><div >V. Kalia, S. Sarkar, Regulation of effector and memory CD8 T cell differentiation by IL-2—A balancing act. Front. Immunol. <b>9</b>, 2987 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >23</div><div ><div ><div >T. Kaartinen, A. Luostarinen, P. Maliniemi, J. Keto, M. Arvas, H. Belt, J. Koponen, P. I. Makinen, A. Loskog, S. Mustjoki, K. Porkka, S. Yla-Herttuala, M. Korhonen, Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion. Cytotherapy <b>19</b>, 689–702 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >24</div><div ><div ><div >A. M. Ring, J. X. Lin, D. Feng, S. Mitra, M. Rickert, G. R. Bowman, V. S. Pande, P. Li, I. Moraga, R. Spolski, E. Ozkan, W. J. Leonard, K. C. Garcia, Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. <b>13</b>, 1187–1195 (2012).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >25</div><div ><div ><div >J. C. Yang, R. M. Sherry, S. M. Steinberg, S. L. Topalian, D. J. Schwartzentruber, P. Hwu, C. A. Seipp, L. Rogers-Freezer, K. E. Morton, D. E. White, D. J. Liewehr, M. J. Merino, S. A. Rosenberg, Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J. Clin. Oncol. <b>21</b>, 3127–3132 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >26</div><div ><div ><div >S. A. Rosenberg, M. T. Lotze, J. C. Yang, P. M. Aebersold, W. M. Linehan, C. A. Seipp, D. E. White, Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg. <b>210</b>, 474–484; discussion 484–485 (1989).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >27</div><div ><div ><div >F. L. Locke, S. S. Neelapu, N. L. Bartlett, T. Siddiqi, J. C. Chavez, C. M. Hosing, A. Ghobadi, L. E. Budde, A. Bot, J. M. Rossi, Y. Jiang, A. X. Xue, M. Elias, J. Aycock, J. Wiezorek, W. Y. Go, Phase 1 results of ZUMA-1: A multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma. Mol. Ther. <b>25</b>, 285–295 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >28</div><div ><div ><div >J. N. Kochenderfer, R. P. T. Somerville, T. Lu, V. Shi, A. Bot, J. Rossi, A. Xue, S. L. Goff, J. C. Yang, R. M. Sherry, C. A. Klebanoff, U. S. Kammula, M. Sherman, A. Perez, C. M. Yuan, T. Feldman, J. W. Friedberg, M. J. Roschewski, S. A. Feldman, L. McIntyre, M. A. Toomey, S. A. Rosenberg, Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels. J. Clin. Oncol. <b>35</b>, 1803–1813 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >29</div><div ><div ><div >N. N. Shah, T. J. Fry, Mechanisms of resistance to CAR T cell therapy. Nat. Rev. Clin. Oncol. <b>16</b>, 372–385 (2019).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >30</div><div ><div ><div >H. Yssel, H. Spits, Generation and maintenance of cloned human T cell lines. Curr. Protoc. Immunol. <b>Chapter 7</b>, Unit 7.19 (2002).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >31</div><div ><div ><div >M. J. Robertson, K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, J. Ritz, Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. <b>24</b>, 406–415 (1996).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >32</div><div ><div ><div >H. Yssel, J. E. De Vries, M. Koken, W. Van Blitterswijk, H. Spits, Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods <b>72</b>, 219–227 (1984).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >33</div><div ><div ><div >J. Charan, N. D. Kantharia, How to calculate sample size in animal studies? J. Pharmacol. Pharmacother <b>4</b>, 303–306 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div></section></div></section><div ><div ><header><h2>Information Authors</h2></header><section ><h3>Information</h3><section ><h4>Published In</h4><div > <div ><div >Science Translational Medicine</div><div >Volume 13 | Issue 625December 2021</div></div></div></section><section ><h4>Copyright</h4><div >Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div >https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div >This is an article distributed under the terms of the Science Journals Default License.</div></section><section ><h4>Submission history</h4><div><b >Received</b>: 26 January 2021</div><div><b >Accepted</b>: 16 November 2021</div></section><section ><h4>Permissions</h4><div>Request permissions for this article.</div><div><a >Request Permissions</a></div></section><section ><h4>Acknowledgments</h4><div >We thank all those at Synthekine for helpful discussions and laboratory support.</div><div ><b>Funding:</b> The research was supported by Synthekine Inc.</div><div ><b>Author contributions:</b> Experiments were conceived and designed by P.-J.A., R.A.K., P.J.L., and M.O. Experiments were performed and data were analyzed by P.-J.A., S.V., M.B., M.S., N.R., R.R., R.d.W.M., D.R., J.E., and S.M. P.-J.A. and M.O. wrote the paper.</div><div ><b>Competing interests:</b> All authors are current employees and shareholders of Synthekine Inc.</div><div ><b>Data and materials availability:</b> All data associated with this study are present in the paper or the Supplementary Materials.</div></section></section><section ><h3>Authors</h3><section ><h4>Affiliations</h4><div ><div >Paul-Joseph Aspuria https://orcid.org/0000-0002-3425-846X</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Sandro Vivona https://orcid.org/0000-0003-2340-3219</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Michele Bauer</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Marie Semana</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Navneet Ratti https://orcid.org/0000-0002-5203-8989</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Scott McCauley https://orcid.org/0000-0003-4549-5599</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Romina Riener https://orcid.org/0000-0001-5005-112X</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Rene de Waal Malefyt https://orcid.org/0000-0002-2663-383X</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Deepti Rokkam</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Jan Emmerich https://orcid.org/0000-0002-7216-2231</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Rob A. Kastelein https://orcid.org/0000-0001-5548-4696</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Patrick J. Lupardus https://orcid.org/0000-0002-8662-074X</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Martin Oft<sup >*</sup> https://orcid.org/0000-0001-9833-2326 [email protected]</div><div ><div ><div >Synthekine, Menlo Park, CA 94025, USA.</div></div><div >View all articles by this author</div></div></div></section><section ><h4>Notes</h4><div >*Corresponding author. Email: [email protected]</div></section></section></div><div ><header><h2>Metrics Citations</h2></header><section ><h3>Metrics</h3><section > <h5 > Article Usage </h5> </section><section > <h5 > Altmetrics </h5> </section></section><section ><h3>Citations</h3><section > <div > <h5 >Export citation</h5> <p>Select the format you want to export the citation of this publication.</p> </div> <div > <h5 > Cited by </h5> <section ><div ><div ><ol ><li ><ul ><li >Qian Zhang, </li><li >Morgan E. Hresko, </li><li >Lora K. Picton, </li><li >Leon Su, </li><li >Michael J. Hollander, </li><li >Selene Nunez-Cruz, </li><li >Zheng Zhang, </li><li >Charles-Antoine Assenmacher, </li><li >Jonathan T. Sockolosky, </li><li >K. Christopher Garcia, </li><li >Michael C. Milone, </li></ul>A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia, Science Translational Medicine, 13, 625, (2021)./doi/10.1126/scitranslmed.abg6986<div >Abstract</div></li></ol></div><div ><div >Loading...</div></div></div></section> </div> </section></section></div><div ><header><h2>View Options</h2></header><div ><h3>Get Access</h3><section > <div ><h5>Log in to view the full text</h5> <p><a >AAAS Log in</a></p> <p>AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul > <li >Become a AAAS Member</li> <li >Activate your Account</li> <li ><a >Purchase Access to Other Journals in the Science Family</a></li> <li><a >Account Help</a></li> </ul> <div > <div >Log in via OpenAthens. <div ><a >via OpenAthens</a></div> </div> <div >Log in via Shibboleth. <div ><a >via Shibboleth</a></div> </div> </div> </div> <div ><h4>More options</h4><p><a >Purchase digital access to this article</a></p><p >Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div><div ><h3>View options</h3><section ><h4>PDF format</h4><p>Download this article as a PDF file</p><a >Download PDF</a></section></div></div><div ><header><h2>Media</h2></header><section ><h3>Figures</h3></section><section ><h3>Multimedia</h3></section></div><div ><header><h2>Tables</h2></header></div><div ><header><h2>Share</h2></header><h3>Share</h3><div ><section ><h4>Share article link</h4><div ><a >Copy Link</a><div ><p >Copied!</p><p >Copying failed.</p></div></div></section><section ><h4>Share on social media</h4><div >facebook<a >twitter</a><a >linkedin</a><a >email</a></div></section></div></div></div></article><section ><div ><div ><div ><div ><h3 >Submit a Response to This Article</h3></div></div></div></div> <div > <div > <h2 >(0)eLetters</h2> </div> <p >eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> <a >Log In to Submit a Response</a> <p >No eLetters have been published for this article yet.</p> </div> </section> <div ><a >View Full Text</a><a >Download PDF</a></div> </div></div></div></div><div ><div ><div ><div ><section><div ><h4 > Current Issue </h4><div ><div > <div ><div><article ><div ><div ><h3 ><a >Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul ><li >By<ul > <li >Jay-Hyun Jo</li> <li >Catriona P. Harkins</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul ><li >By<ul > <li >Qian Zhang</li> <li >Morgan E. Hresko</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul ><li >By<ul > <li >Paul-Joseph Aspuria</li> <li >Sandro Vivona</li> <li >et al.</li> </ul> </li></ul></div></div></article></div><div ><a >Table of Contents</a></div></div> </div></div></div></section><section > <h4 >LATEST NEWS</h4> <div > <div ><div > <article > <div > <div > News<time >30 Dec 2021</time> </div> <div > Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article > <div > <div > ScienceInsider<time >29 Dec 2021</time> </div> <div > Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > The natural world loses two of its biggest advocates </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > <a > What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >25 Dec 2021</time> </div> <div > NASA’s Webb telescope takes flight—a Christmas gift to astronomers everywhere </div> </div> </article> <article > <div > <div > News<time >23 Dec 2021</time> </div> <div > <a > More than a virus: Science’s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57"><a title="valid: False, node: 58, tag: a, level: 16" node_number="58">Anywhere</a><a title="valid: False, node: 59, tag: a, level: 16" node_number="59">Science</a><a title="valid: False, node: 60, tag: a, level: 16" node_number="60">Science Advances</a><a title="valid: False, node: 61, tag: a, level: 16" node_number="61">Science Immunology</a><a title="valid: False, node: 62, tag: a, level: 16" node_number="62">Science Robotics</a><a title="valid: False, node: 63, tag: a, level: 16" node_number="63">Science Signaling</a><a title="valid: False, node: 64, tag: a, level: 16" node_number="64">Science Translational Medicine</a></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 12" node_number="65"> <a class="valid" valid="valid" title="valid: True, node: 66, tag: a, level: 13" node_number="66"><u class="valid" valid="valid" title="valid: True, node: 67, tag: u, level: 14" node_number="67">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 7" node_number="68"> <div class="valid" valid="valid" title="valid: True, node: 69, tag: div, level: 8" node_number="69"> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 9" node_number="70"> <h6 class="valid" valid="valid" title="valid: True, node: 71, tag: h6, level: 10" node_number="71">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 72, tag: ul, level: 10" node_number="72"> <li class="valid" valid="valid" title="valid: True, node: 73, tag: li, level: 11" node_number="73"> <a class="valid" valid="valid" title="valid: True, node: 74, tag: a, level: 12" node_number="74">covid-19</a> </li> <li class="valid" valid="valid" title="valid: True, node: 75, tag: li, level: 11" node_number="75"> <a class="valid" valid="valid" title="valid: True, node: 76, tag: a, level: 12" node_number="76">climate</a> </li> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> <a class="valid" valid="valid" title="valid: True, node: 78, tag: a, level: 12" node_number="78">science policy</a> </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> <a class="valid" valid="valid" title="valid: True, node: 80, tag: a, level: 12" node_number="80">genome editing</a> </li> <li class="valid" valid="valid" title="valid: True, node: 81, tag: li, level: 11" node_number="81"> <a class="valid" valid="valid" title="valid: True, node: 82, tag: a, level: 12" node_number="82">batteries</a> </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 5" node_number="83"><div class="valid" valid="valid" title="valid: True, node: 84, tag: div, level: 6" node_number="84"><div class="valid" valid="valid" title="valid: True, node: 85, tag: div, level: 7" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 8" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 9" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 10" node_number="88"> <li class="valid" valid="valid" title="valid: True, node: 89, tag: li, level: 11" node_number="89"> <a class="valid" valid="valid" title="valid: True, node: 90, tag: a, level: 12" node_number="90">Current Issue</a> </li> <li class="valid" valid="valid" title="valid: True, node: 91, tag: li, level: 11" node_number="91"> <a class="valid" valid="valid" title="valid: True, node: 92, tag: a, level: 12" node_number="92">First release papers</a> </li> <li class="valid" valid="valid" title="valid: True, node: 93, tag: li, level: 11" node_number="93"> <a class="valid" valid="valid" title="valid: True, node: 94, tag: a, level: 12" node_number="94">Archive</a> </li> <li class="valid" valid="valid" title="valid: True, node: 95, tag: li, level: 11" node_number="95"> <div class="valid" valid="valid" title="valid: True, node: 96, tag: div, level: 12" node_number="96"> <a class="valid" valid="valid" title="valid: True, node: 97, tag: a, level: 13" node_number="97">About</a> <div class="valid" valid="valid" title="valid: True, node: 98, tag: div, level: 13" node_number="98"> <a class="valid" valid="valid" title="valid: True, node: 99, tag: a, level: 14" node_number="99">About Science Translational Medicine</a> <a class="valid" valid="valid" title="valid: True, node: 100, tag: a, level: 14" node_number="100">Mission Scope</a> <a class="valid" valid="valid" title="valid: True, node: 101, tag: a, level: 14" node_number="101">Editors and Advisory Boards</a> <a class="valid" valid="valid" title="valid: True, node: 102, tag: a, level: 14" node_number="102">Editorial Policies</a> <a class="valid" valid="valid" title="valid: True, node: 103, tag: a, level: 14" node_number="103">Information for Authors</a> <a class="valid" valid="valid" title="valid: True, node: 104, tag: a, level: 14" node_number="104">Information for Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 105, tag: a, level: 14" node_number="105">Journal Metrics</a> <a class="valid" valid="valid" title="valid: True, node: 106, tag: a, level: 14" node_number="106">Staff</a> <a class="valid" valid="valid" title="valid: True, node: 107, tag: a, level: 14" node_number="107">Contact Us</a> <a class="valid" valid="valid" title="valid: True, node: 108, tag: a, level: 14" node_number="108">Subscribe</a> <a class="valid" valid="valid" title="valid: True, node: 109, tag: a, level: 14" node_number="109">Free Sample Articles</a> </div> </div> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 110, tag: div, level: 9" node_number="110"> <ul class="valid" valid="valid" title="valid: True, node: 111, tag: ul, level: 10" node_number="111"> <li class="valid" valid="valid" title="valid: True, node: 112, tag: li, level: 11" node_number="112"> <a class="valid" valid="valid" title="valid: True, node: 113, tag: a, level: 12" node_number="113">Submit manuscript</a> </li> <li class="valid" valid="valid" title="valid: True, node: 114, tag: li, level: 11" node_number="114"> <div class="valid" valid="valid" title="valid: True, node: 115, tag: div, level: 12" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 13" node_number="116">More</a> </div> </li> </ul> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 117, tag: a, level: 8" node_number="117">GET OUR E-ALERTS</a> </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 118, tag: main, level: 5" node_number="118"> <div class="valid" valid="valid" title="valid: True, node: 119, tag: div, level: 6" node_number="119"><div class="valid" valid="valid" title="valid: True, node: 120, tag: div, level: 7" node_number="120"><div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 8" node_number="121"><div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 9" node_number="122"><div class="valid" valid="valid" title="valid: True, node: 123, tag: div, level: 10" node_number="123"> <div class="valid" valid="valid" title="valid: True, node: 124, tag: div, level: 11" node_number="124"><a class="valid" valid="valid" title="valid: True, node: 125, tag: a, level: 12" node_number="125">Home</a><a class="valid" valid="valid" title="valid: True, node: 126, tag: a, level: 12" node_number="126">Science Translational Medicine</a><a class="valid" valid="valid" title="valid: True, node: 127, tag: a, level: 12" node_number="127">Vol. 13, No. 625</a>An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</div><div class="valid" valid="valid" title="valid: True, node: 128, tag: div, level: 11" node_number="128">Back To Vol. 13, No. 625</div> </div> <article class="valid" valid="valid" title="valid: True, node: 129, tag: article, level: 10" node_number="129"><section class="valid" valid="valid" title="valid: True, node: 130, tag: section, level: 11" node_number="130"><header class="valid" valid="valid" title="valid: True, node: 131, tag: header, level: 12" node_number="131"><div class="valid" valid="valid" title="valid: True, node: 132, tag: div, level: 13" node_number="132"><div class="valid" valid="valid" title="valid: True, node: 133, tag: div, level: 14" node_number="133"><div title="valid: False, node: 134, tag: div, level: 15" node_number="134"><div title="valid: False, node: 135, tag: div, level: 16" node_number="135">Research Article</div><div title="valid: False, node: 136, tag: div, level: 16" node_number="136">CANCER</div></div><div title="valid: False, node: 137, tag: div, level: 15" node_number="137"><div title="valid: False, node: 138, tag: div, level: 16" node_number="138"> <div title="valid: False, node: 139, tag: div, level: 17" node_number="139">Share on</div> </div></div></div><h1 class="valid" valid="valid" title="valid: True, node: 140, tag: h1, level: 14" node_number="140">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h1><div class="valid" valid="valid" title="valid: True, node: 141, tag: div, level: 14" node_number="141">Paul-Joseph Aspuria https://orcid.org/0000-0002-3425-846X, Sandro Vivona https://orcid.org/0000-0003-2340-3219, Michele Bauer, Marie Semana, Navneet Ratti https://orcid.org/0000-0002-5203-8989, Scott McCauley https://orcid.org/0000-0003-4549-5599, Romina Riener https://orcid.org/0000-0001-5005-112X, &#8230; Show All &#8230; , Rene de Waal Malefyt https://orcid.org/0000-0002-2663-383X, Deepti Rokkam, Jan Emmerich https://orcid.org/0000-0002-7216-2231, Rob A. Kastelein https://orcid.org/0000-0001-5548-4696, Patrick J. Lupardus https://orcid.org/0000-0002-8662-074X, and Martin Oft https://orcid.org/0000-0001-9833-2326 [email&#160;protected] Show Fewer</div><div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 14" node_number="142">Science Translational Medicine &#8226; 22 Dec 2021 &#8226; Vol 13, Issue 625 &#8226; DOI: 10.1126/scitranslmed.abg7565</div><div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 14" node_number="143"><div title="valid: False, node: 144, tag: div, level: 15" node_number="144"> <div title="valid: False, node: 145, tag: div, level: 16" node_number="145"> <a title="valid: False, node: 146, tag: a, level: 17" node_number="146"><div title="valid: False, node: 147, tag: div, level: 18" node_number="147"><div title="valid: False, node: 148, tag: div, level: 19" node_number="148"><h6 title="valid: False, node: 149, tag: h6, level: 20" node_number="149">PREVIOUS ARTICLE</h6><div title="valid: False, node: 150, tag: div, level: 20" node_number="150">A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</div></div></div>Previous</a><a title="valid: False, node: 151, tag: a, level: 17" node_number="151"><div title="valid: False, node: 152, tag: div, level: 18" node_number="152"><div title="valid: False, node: 153, tag: div, level: 19" node_number="153"><h6 title="valid: False, node: 154, tag: h6, level: 20" node_number="154">NEXT ARTICLE</h6><div title="valid: False, node: 155, tag: div, level: 20" node_number="155">Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria</div></div></div>Next</a> </div> </div><div title="valid: False, node: 156, tag: div, level: 15" node_number="156"><div title="valid: False, node: 157, tag: div, level: 16" node_number="157">get access</div></div></div></div></header><div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 12" node_number="158"><div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 13" node_number="159"><section class="valid" valid="valid" title="valid: True, node: 160, tag: section, level: 14" node_number="160"><h2 title="valid: False, node: 161, tag: h2, level: 15" node_number="161">An orthogonal approach to cancer</h2><div title="valid: False, node: 162, tag: div, level: 15" node_number="162">Interleukin-2 (IL-2) is an important cytokine for T cell activation and has been considered as a treatment for cancer. However, systemic administration of IL-2 often leads to severe toxicity. To address this, Zhang <i title="valid: False, node: 163, tag: i, level: 16" node_number="163">et al.</i> and Aspuria <i title="valid: False, node: 164, tag: i, level: 16" node_number="164">et al.</i> engineered T cells to express an IL-2 receptor &#946; (IL-2R&#946;) that can only be activated by a modified, orthogonal IL-2. Orthogonal IL-2R&#946; was introduced to CAR T cells targeting CD19, and the CAR T cells were transferred to mice bearing leukemias or lymphomas. Administration of orthogonal IL-2 to CAR T cell recipients drove activation, expansion, and antitumor efficacy of CAR T cells in both preclinical models with limited systemic toxicity. Thus, orthogonal cytokine-receptor pairs may offer a safer approach to enhance adoptive cell therapy.</div></section><section class="valid" valid="valid" title="valid: True, node: 165, tag: section, level: 14" node_number="165"><h2 title="valid: False, node: 166, tag: h2, level: 15" node_number="166">Abstract</h2><div title="valid: False, node: 167, tag: div, level: 15" node_number="167">Chimeric antigen receptor (CAR) T cells induce durable responses in patients with refractory hematological tumors. However, low CAR T cell activity, poor engraftment, or short in-patient persistence can lead to tumor progression or relapse. Furthermore, excessive CAR T cell expansion and activation can result in life-threatening cytokine release syndrome (CRS). Thus, in-patient control of the CAR T cell population is essential. Interleukin-2 (IL-2) is a critical cytokine for T cell proliferation and effector function, but its clinical use is limited by immune-mediated toxicity. Here, we report on an orthogonal IL-2 receptor and ligand system that enables specific in vivo control of CAR T cell expansion and activation, wherein an orthogonal human IL-2 (STK-009) selectively pairs with an orthogonal human IL-2R&#946; (hoRb) expressed on CAR T cells. STK-009 expands hoRb-expressing CAR T cells in the presence and absence of tumor antigen and maintains the presence of stem cell memory T cells (T<sub title="valid: False, node: 168, tag: sub, level: 16" node_number="168">SCM</sub>) and effector T cells. In preclinical models of human CAR-refractory lymphoma, STK-009 treatment resulted in systemic and intratumoral expansion and activation of hoRb-expressing anti&#8211;CD19-CD28&#950; CAR T cells (SYNCAR). The orthogonal IL-2 receptor/ligand system delivers complete responses in large subcutaneous lymphomas, even with substantially reduced CAR T cell doses, by selectively expanding and activating CAR T cells in vivo. STK-009 withdrawal allowed normal CAR T cell contraction, thereby limiting CRS induced by tumor antigen&#8211;specific T cell activation. These data suggest that the orthogonal IL-2 receptor/ligand system provides the in vivo control necessary to maximize efficacy of CAR T therapies.</div></section></div></div></section><section class="valid" valid="valid" title="valid: True, node: 169, tag: section, level: 11" node_number="169"><div class="valid" valid="valid" title="valid: True, node: 170, tag: div, level: 12" node_number="170"><div class="valid" valid="valid" title="valid: True, node: 171, tag: div, level: 13" node_number="171"><div class="valid" valid="valid" title="valid: True, node: 172, tag: div, level: 14" node_number="172"><h5 title="valid: False, node: 173, tag: h5, level: 15" node_number="173">Get full access to this article</h5><p title="valid: False, node: 174, tag: p, level: 15" node_number="174">View all available purchase options and get full access to this article.</p><div title="valid: False, node: 175, tag: div, level: 15" node_number="175"> Get Access</div><div title="valid: False, node: 176, tag: div, level: 15" node_number="176">Already a Subscriber?Sign In</div></div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 177, tag: section, level: 11" node_number="177"><div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 12" node_number="178"><section class="valid" valid="valid" title="valid: True, node: 179, tag: section, level: 13" node_number="179"><h2 class="valid" valid="valid" title="valid: True, node: 180, tag: h2, level: 14" node_number="180">Supplementary Materials</h2><section class="valid" valid="valid" title="valid: True, node: 181, tag: section, level: 14" node_number="181"><h3 title="valid: False, node: 182, tag: h3, level: 15" node_number="182">This PDF file includes:</h3><div title="valid: False, node: 183, tag: div, level: 15" node_number="183"><div title="valid: False, node: 184, tag: div, level: 16" node_number="184"><div title="valid: False, node: 185, tag: div, level: 17" node_number="185">Figs. S1 to S7</div></div><div title="valid: False, node: 186, tag: div, level: 16" node_number="186"><a title="valid: False, node: 187, tag: a, level: 17" node_number="187">Download (1.50 MB)</a></div></div></section><section class="valid" valid="valid" title="valid: True, node: 188, tag: section, level: 14" node_number="188"><h3 title="valid: False, node: 189, tag: h3, level: 15" node_number="189">Other Supplementary Material for this manuscript includes the following:</h3><div title="valid: False, node: 190, tag: div, level: 15" node_number="190"><div title="valid: False, node: 191, tag: div, level: 16" node_number="191"><div title="valid: False, node: 192, tag: div, level: 17" node_number="192">Data file S1</div></div><div title="valid: False, node: 193, tag: div, level: 16" node_number="193"><a title="valid: False, node: 194, tag: a, level: 17" node_number="194">Download (83.48 KB)</a></div></div></section></section><div class="valid" valid="valid" title="valid: True, node: 195, tag: div, level: 13" node_number="195"><a class="valid" valid="valid" title="valid: True, node: 196, tag: a, level: 14" node_number="196">View/request a protocol for this paper from <i title="valid: False, node: 197, tag: i, level: 15" node_number="197">Bio-protocol</i>.</a></div><section class="valid" valid="valid" title="valid: True, node: 198, tag: section, level: 13" node_number="198"><h2 class="valid" valid="valid" title="valid: True, node: 199, tag: h2, level: 14" node_number="199">References and Notes</h2><div class="valid" valid="valid" title="valid: True, node: 200, tag: div, level: 14" node_number="200"><div title="valid: False, node: 201, tag: div, level: 15" node_number="201">1</div><div title="valid: False, node: 202, tag: div, level: 15" node_number="202"><div title="valid: False, node: 203, tag: div, level: 16" node_number="203"><div title="valid: False, node: 204, tag: div, level: 17" node_number="204">S. S. Neelapu, F. L. Locke, N. L. Bartlett, L. J. Lekakis, D. B. Miklos, C. A. Jacobson, I. Braunschweig, O. O. Oluwole, T. Siddiqi, Y. Lin, J. M. Timmerman, P. J. Stiff, J. W. Friedberg, I. W. Flinn, A. Goy, B. T. Hill, M. R. Smith, A. Deol, U. Farooq, P. McSweeney, J. Munoz, I. Avivi, J. E. Castro, J. R. Westin, J. C. Chavez, A. Ghobadi, K. V. Komanduri, R. Levy, E. D. Jacobsen, T. E. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Y. Jiang, J. Aycock, M. Elias, D. Chang, J. Wiezorek, W. Y. Go, Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl. J. Med. <b title="valid: False, node: 205, tag: b, level: 18" node_number="205">377</b>, 2531&#8211;2544 (2017).</div><div title="valid: False, node: 206, tag: div, level: 17" node_number="206"><div title="valid: False, node: 207, tag: div, level: 18" node_number="207"><a title="valid: False, node: 208, tag: a, level: 19" node_number="208">Crossref</a></div><div title="valid: False, node: 209, tag: div, level: 18" node_number="209"><a title="valid: False, node: 210, tag: a, level: 19" node_number="210">PubMed</a></div><div title="valid: False, node: 211, tag: div, level: 18" node_number="211"><a title="valid: False, node: 212, tag: a, level: 19" node_number="212">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 213, tag: div, level: 14" node_number="213"><div title="valid: False, node: 214, tag: div, level: 15" node_number="214">2</div><div title="valid: False, node: 215, tag: div, level: 15" node_number="215"><div title="valid: False, node: 216, tag: div, level: 16" node_number="216"><div title="valid: False, node: 217, tag: div, level: 17" node_number="217">S. J. Schuster, M. R. Bishop, C. S. Tam, E. K. Waller, P. Borchmann, J. P. McGuirk, U. Jager, S. Jaglowski, C. Andreadis, J. R. Westin, I. Fleury, V. Bachanova, S. R. Foley, P. J. Ho, S. Mielke, J. M. Magenau, H. Holte, S. Pantano, L. B. Pacaud, R. Awasthi, J. Chu, O. Anak, G. Salles, R. T. Maziarz; JULIET Investigators, Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. <b title="valid: False, node: 218, tag: b, level: 18" node_number="218">380</b>, 45&#8211;56 (2019).</div><div title="valid: False, node: 219, tag: div, level: 17" node_number="219"><div title="valid: False, node: 220, tag: div, level: 18" node_number="220"><a title="valid: False, node: 221, tag: a, level: 19" node_number="221">Crossref</a></div><div title="valid: False, node: 222, tag: div, level: 18" node_number="222"><a title="valid: False, node: 223, tag: a, level: 19" node_number="223">PubMed</a></div><div title="valid: False, node: 224, tag: div, level: 18" node_number="224"><a title="valid: False, node: 225, tag: a, level: 19" node_number="225">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 226, tag: div, level: 14" node_number="226"><div title="valid: False, node: 227, tag: div, level: 15" node_number="227">3</div><div title="valid: False, node: 228, tag: div, level: 15" node_number="228"><div title="valid: False, node: 229, tag: div, level: 16" node_number="229"><div title="valid: False, node: 230, tag: div, level: 17" node_number="230">S. L. Maude, N. Frey, P. A. Shaw, R. Aplenc, D. M. Barrett, N. J. Bunin, A. Chew, V. E. Gonzalez, Z. Zheng, S. F. Lacey, Y. D. Mahnke, J. J. Melenhorst, S. R. Rheingold, A. Shen, D. T. Teachey, B. L. Levine, C. H. June, D. L. Porter, S. A. Grupp, Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. <b title="valid: False, node: 231, tag: b, level: 18" node_number="231">371</b>, 1507&#8211;1517 (2014).</div><div title="valid: False, node: 232, tag: div, level: 17" node_number="232"><div title="valid: False, node: 233, tag: div, level: 18" node_number="233"><a title="valid: False, node: 234, tag: a, level: 19" node_number="234">Crossref</a></div><div title="valid: False, node: 235, tag: div, level: 18" node_number="235"><a title="valid: False, node: 236, tag: a, level: 19" node_number="236">PubMed</a></div><div title="valid: False, node: 237, tag: div, level: 18" node_number="237"><a title="valid: False, node: 238, tag: a, level: 19" node_number="238">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 239, tag: div, level: 14" node_number="239"><div title="valid: False, node: 240, tag: div, level: 15" node_number="240">4</div><div title="valid: False, node: 241, tag: div, level: 15" node_number="241"><div title="valid: False, node: 242, tag: div, level: 16" node_number="242"><div title="valid: False, node: 243, tag: div, level: 17" node_number="243">M. Wang, J. Munoz, A. Goy, F. L. Locke, C. A. Jacobson, B. T. Hill, J. M. Timmerman, H. Holmes, S. Jaglowski, I. W. Flinn, P. A. McSweeney, D. B. Miklos, J. M. Pagel, M. J. Kersten, N. Milpied, H. Fung, M. S. Topp, R. Houot, A. Beitinjaneh, W. Peng, L. Zheng, J. M. Rossi, R. K. Jain, A. V. Rao, P. M. Reagan, KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. <b title="valid: False, node: 244, tag: b, level: 18" node_number="244">382</b>, 1331&#8211;1342 (2020).</div><div title="valid: False, node: 245, tag: div, level: 17" node_number="245"><div title="valid: False, node: 246, tag: div, level: 18" node_number="246"><a title="valid: False, node: 247, tag: a, level: 19" node_number="247">Crossref</a></div><div title="valid: False, node: 248, tag: div, level: 18" node_number="248"><a title="valid: False, node: 249, tag: a, level: 19" node_number="249">PubMed</a></div><div title="valid: False, node: 250, tag: div, level: 18" node_number="250"><a title="valid: False, node: 251, tag: a, level: 19" node_number="251">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 252, tag: div, level: 14" node_number="252"><div title="valid: False, node: 253, tag: div, level: 15" node_number="253">5</div><div title="valid: False, node: 254, tag: div, level: 15" node_number="254"><div title="valid: False, node: 255, tag: div, level: 16" node_number="255"><div title="valid: False, node: 256, tag: div, level: 17" node_number="256">C. H. June, R. S. O&#8217;Connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, CAR T cell immunotherapy for human cancer. Science <b title="valid: False, node: 257, tag: b, level: 18" node_number="257">359</b>, 1361&#8211;1365 (2018).</div><div title="valid: False, node: 258, tag: div, level: 17" node_number="258"><div title="valid: False, node: 259, tag: div, level: 18" node_number="259"><a title="valid: False, node: 260, tag: a, level: 19" node_number="260">Crossref</a></div><div title="valid: False, node: 261, tag: div, level: 18" node_number="261"><a title="valid: False, node: 262, tag: a, level: 19" node_number="262">PubMed</a></div><div title="valid: False, node: 263, tag: div, level: 18" node_number="263"><a title="valid: False, node: 264, tag: a, level: 19" node_number="264">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 265, tag: div, level: 14" node_number="265"><div title="valid: False, node: 266, tag: div, level: 15" node_number="266">6</div><div title="valid: False, node: 267, tag: div, level: 15" node_number="267"><div title="valid: False, node: 268, tag: div, level: 16" node_number="268"><div title="valid: False, node: 269, tag: div, level: 17" node_number="269">J. N. Kochenderfer, M. E. Dudley, S. A. Feldman, W. H. Wilson, D. E. Spaner, I. Maric, M. Stetler-Stevenson, G. Q. Phan, M. S. Hughes, R. M. Sherry, J. C. Yang, U. S. Kammula, L. Devillier, R. Carpenter, D. A. Nathan, R. A. Morgan, C. Laurencot, S. A. Rosenberg, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood <b title="valid: False, node: 270, tag: b, level: 18" node_number="270">119</b>, 2709&#8211;2720 (2012).</div><div title="valid: False, node: 271, tag: div, level: 17" node_number="271"><div title="valid: False, node: 272, tag: div, level: 18" node_number="272"><a title="valid: False, node: 273, tag: a, level: 19" node_number="273">Crossref</a></div><div title="valid: False, node: 274, tag: div, level: 18" node_number="274"><a title="valid: False, node: 275, tag: a, level: 19" node_number="275">PubMed</a></div><div title="valid: False, node: 276, tag: div, level: 18" node_number="276"><a title="valid: False, node: 277, tag: a, level: 19" node_number="277">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 278, tag: div, level: 14" node_number="278"><div title="valid: False, node: 279, tag: div, level: 15" node_number="279">7</div><div title="valid: False, node: 280, tag: div, level: 15" node_number="280"><div title="valid: False, node: 281, tag: div, level: 16" node_number="281"><div title="valid: False, node: 282, tag: div, level: 17" node_number="282">K. A. Hay, L. A. Hanafi, D. Li, J. Gust, W. C. Liles, M. M. Wurfel, J. A. Lopez, J. Chen, D. Chung, S. Harju-Baker, S. Cherian, X. Chen, S. R. Riddell, D. G. Maloney, C. J. Turtle, Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood <b title="valid: False, node: 283, tag: b, level: 18" node_number="283">130</b>, 2295&#8211;2306 (2017).</div><div title="valid: False, node: 284, tag: div, level: 17" node_number="284"><div title="valid: False, node: 285, tag: div, level: 18" node_number="285"><a title="valid: False, node: 286, tag: a, level: 19" node_number="286">Crossref</a></div><div title="valid: False, node: 287, tag: div, level: 18" node_number="287"><a title="valid: False, node: 288, tag: a, level: 19" node_number="288">PubMed</a></div><div title="valid: False, node: 289, tag: div, level: 18" node_number="289"><a title="valid: False, node: 290, tag: a, level: 19" node_number="290">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 291, tag: div, level: 14" node_number="291"><div title="valid: False, node: 292, tag: div, level: 15" node_number="292">8</div><div title="valid: False, node: 293, tag: div, level: 15" node_number="293"><div title="valid: False, node: 294, tag: div, level: 16" node_number="294"><div title="valid: False, node: 295, tag: div, level: 17" node_number="295">C. J. Turtle, L. A. Hanafi, C. Berger, T. A. Gooley, S. Cherian, M. Hudecek, D. Sommermeyer, K. Melville, B. Pender, T. M. Budiarto, E. Robinson, N. N. Steevens, C. Chaney, L. Soma, X. Chen, C. Yeung, B. Wood, D. Li, J. Cao, S. Heimfeld, M. C. Jensen, S. R. Riddell, D. G. Maloney, CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J. Clin. Invest. <b title="valid: False, node: 296, tag: b, level: 18" node_number="296">126</b>, 2123&#8211;2138 (2016).</div><div title="valid: False, node: 297, tag: div, level: 17" node_number="297"><div title="valid: False, node: 298, tag: div, level: 18" node_number="298"><a title="valid: False, node: 299, tag: a, level: 19" node_number="299">Crossref</a></div><div title="valid: False, node: 300, tag: div, level: 18" node_number="300"><a title="valid: False, node: 301, tag: a, level: 19" node_number="301">PubMed</a></div><div title="valid: False, node: 302, tag: div, level: 18" node_number="302"><a title="valid: False, node: 303, tag: a, level: 19" node_number="303">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 304, tag: div, level: 14" node_number="304"><div title="valid: False, node: 305, tag: div, level: 15" node_number="305">9</div><div title="valid: False, node: 306, tag: div, level: 15" node_number="306"><div title="valid: False, node: 307, tag: div, level: 16" node_number="307"><div title="valid: False, node: 308, tag: div, level: 17" node_number="308">M. B. Atkins, M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. A. Rosenberg, High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. <b title="valid: False, node: 309, tag: b, level: 18" node_number="309">17</b>, 2105&#8211;2116 (1999).</div><div title="valid: False, node: 310, tag: div, level: 17" node_number="310"><div title="valid: False, node: 311, tag: div, level: 18" node_number="311"><a title="valid: False, node: 312, tag: a, level: 19" node_number="312">Crossref</a></div><div title="valid: False, node: 313, tag: div, level: 18" node_number="313"><a title="valid: False, node: 314, tag: a, level: 19" node_number="314">PubMed</a></div><div title="valid: False, node: 315, tag: div, level: 18" node_number="315"><a title="valid: False, node: 316, tag: a, level: 19" node_number="316">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 317, tag: div, level: 14" node_number="317"><div title="valid: False, node: 318, tag: div, level: 15" node_number="318">10</div><div title="valid: False, node: 319, tag: div, level: 15" node_number="319"><div title="valid: False, node: 320, tag: div, level: 16" node_number="320"><div title="valid: False, node: 321, tag: div, level: 17" node_number="321">D. J. Peace, M. A. Cheever, Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia. J. Exp. Med. <b title="valid: False, node: 322, tag: b, level: 18" node_number="322">169</b>, 161&#8211;173 (1989).</div><div title="valid: False, node: 323, tag: div, level: 17" node_number="323"><div title="valid: False, node: 324, tag: div, level: 18" node_number="324"><a title="valid: False, node: 325, tag: a, level: 19" node_number="325">Crossref</a></div><div title="valid: False, node: 326, tag: div, level: 18" node_number="326"><a title="valid: False, node: 327, tag: a, level: 19" node_number="327">PubMed</a></div><div title="valid: False, node: 328, tag: div, level: 18" node_number="328"><a title="valid: False, node: 329, tag: a, level: 19" node_number="329">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 330, tag: div, level: 14" node_number="330"><div title="valid: False, node: 331, tag: div, level: 15" node_number="331">11</div><div title="valid: False, node: 332, tag: div, level: 15" node_number="332"><div title="valid: False, node: 333, tag: div, level: 16" node_number="333"><div title="valid: False, node: 334, tag: div, level: 17" node_number="334">E. Assier, V. Jullien, J. Lefort, J. L. Moreau, J. P. Di Santo, B. B. Vargaftig, J. R. Lapa e Silva, J. Theze, NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J. Immunol. <b title="valid: False, node: 335, tag: b, level: 18" node_number="335">172</b>, 7661&#8211;7668 (2004).</div><div title="valid: False, node: 336, tag: div, level: 17" node_number="336"><div title="valid: False, node: 337, tag: div, level: 18" node_number="337"><a title="valid: False, node: 338, tag: a, level: 19" node_number="338">Crossref</a></div><div title="valid: False, node: 339, tag: div, level: 18" node_number="339"><a title="valid: False, node: 340, tag: a, level: 19" node_number="340">PubMed</a></div><div title="valid: False, node: 341, tag: div, level: 18" node_number="341"><a title="valid: False, node: 342, tag: a, level: 19" node_number="342">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 343, tag: div, level: 14" node_number="343"><div title="valid: False, node: 344, tag: div, level: 15" node_number="344">12</div><div title="valid: False, node: 345, tag: div, level: 15" node_number="345"><div title="valid: False, node: 346, tag: div, level: 16" node_number="346"><div title="valid: False, node: 347, tag: div, level: 17" node_number="347">J. T. Sockolosky, E. Trotta, G. Parisi, L. Picton, L. L. Su, A. C. Le, A. Chhabra, S. L. Silveria, B. M. George, I. C. King, M. R. Tiffany, K. Jude, L. V. Sibener, D. Baker, J. A. Shizuru, A. Ribas, J. A. Bluestone, K. C. Garcia, Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science <b title="valid: False, node: 348, tag: b, level: 18" node_number="348">359</b>, 1037&#8211;1042 (2018).</div><div title="valid: False, node: 349, tag: div, level: 17" node_number="349"><div title="valid: False, node: 350, tag: div, level: 18" node_number="350"><a title="valid: False, node: 351, tag: a, level: 19" node_number="351">Crossref</a></div><div title="valid: False, node: 352, tag: div, level: 18" node_number="352"><a title="valid: False, node: 353, tag: a, level: 19" node_number="353">PubMed</a></div><div title="valid: False, node: 354, tag: div, level: 18" node_number="354"><a title="valid: False, node: 355, tag: a, level: 19" node_number="355">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 356, tag: div, level: 14" node_number="356"><div title="valid: False, node: 357, tag: div, level: 15" node_number="357">13</div><div title="valid: False, node: 358, tag: div, level: 15" node_number="358"><div title="valid: False, node: 359, tag: div, level: 16" node_number="359"><div title="valid: False, node: 360, tag: div, level: 17" node_number="360">M. J. Grace, S. Lee, S. Bradshaw, J. Chapman, J. Spond, S. Cox, M. Delorenzo, D. Brassard, D. Wylie, S. Cannon-Carlson, C. Cullen, S. Indelicato, M. Voloch, R. Bordens, Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J. Biol. Chem. <b title="valid: False, node: 361, tag: b, level: 18" node_number="361">280</b>, 6327&#8211;6336 (2005).</div><div title="valid: False, node: 362, tag: div, level: 17" node_number="362"><div title="valid: False, node: 363, tag: div, level: 18" node_number="363"><a title="valid: False, node: 364, tag: a, level: 19" node_number="364">Crossref</a></div><div title="valid: False, node: 365, tag: div, level: 18" node_number="365"><a title="valid: False, node: 366, tag: a, level: 19" node_number="366">PubMed</a></div><div title="valid: False, node: 367, tag: div, level: 18" node_number="367"><a title="valid: False, node: 368, tag: a, level: 19" node_number="368">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 369, tag: div, level: 14" node_number="369"><div title="valid: False, node: 370, tag: div, level: 15" node_number="370">14</div><div title="valid: False, node: 371, tag: div, level: 15" node_number="371"><div title="valid: False, node: 372, tag: div, level: 16" node_number="372"><div title="valid: False, node: 373, tag: div, level: 17" node_number="373">P. A. Baeuerle, J. Ding, E. Patel, N. Thorausch, H. Horton, J. Gierut, I. Scarfo, R. Choudhary, O. Kiner, J. Krishnamurthy, B. Le, A. Morath, G. C. Baldeviano, J. Quinn, P. Tavares, Q. Wei, S. Weiler, M. V. Maus, D. Getts, W. W. Schamel, R. Hofmeister, Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response. Nat. Commun. <b title="valid: False, node: 374, tag: b, level: 18" node_number="374">10</b>, 2087 (2019).</div><div title="valid: False, node: 375, tag: div, level: 17" node_number="375"><div title="valid: False, node: 376, tag: div, level: 18" node_number="376"><a title="valid: False, node: 377, tag: a, level: 19" node_number="377">Crossref</a></div><div title="valid: False, node: 378, tag: div, level: 18" node_number="378"><a title="valid: False, node: 379, tag: a, level: 19" node_number="379">PubMed</a></div><div title="valid: False, node: 380, tag: div, level: 18" node_number="380"><a title="valid: False, node: 381, tag: a, level: 19" node_number="381">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 382, tag: div, level: 14" node_number="382"><div title="valid: False, node: 383, tag: div, level: 15" node_number="383">15</div><div title="valid: False, node: 384, tag: div, level: 15" node_number="384"><div title="valid: False, node: 385, tag: div, level: 16" node_number="385"><div title="valid: False, node: 386, tag: div, level: 17" node_number="386">J. S. Abramson, M. Lunning, M. L. Palomba, Chimeric antigen receptor T-cell therapies for aggressive B-cell lymphomas: Current and future state of the art. Am. Soc. Clin. Oncol. Educ. Book <b title="valid: False, node: 387, tag: b, level: 18" node_number="387">39</b>, 446&#8211;453 (2019).</div><div title="valid: False, node: 388, tag: div, level: 17" node_number="388"><div title="valid: False, node: 389, tag: div, level: 18" node_number="389"><a title="valid: False, node: 390, tag: a, level: 19" node_number="390">Crossref</a></div><div title="valid: False, node: 391, tag: div, level: 18" node_number="391"><a title="valid: False, node: 392, tag: a, level: 19" node_number="392">PubMed</a></div><div title="valid: False, node: 393, tag: div, level: 18" node_number="393"><a title="valid: False, node: 394, tag: a, level: 19" node_number="394">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 395, tag: div, level: 14" node_number="395"><div title="valid: False, node: 396, tag: div, level: 15" node_number="396">16</div><div title="valid: False, node: 397, tag: div, level: 15" node_number="397"><div title="valid: False, node: 398, tag: div, level: 16" node_number="398"><div title="valid: False, node: 399, tag: div, level: 17" node_number="399">M. A. Brehm, L. L. Kenney, M. V. Wiles, B. E. Low, R. M. Tisch, L. Burzenski, C. Mueller, D. L. Greiner, L. D. Shultz, Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB J. <b title="valid: False, node: 400, tag: b, level: 18" node_number="400">33</b>, 3137&#8211;3151 (2019).</div><div title="valid: False, node: 401, tag: div, level: 17" node_number="401"><div title="valid: False, node: 402, tag: div, level: 18" node_number="402"><a title="valid: False, node: 403, tag: a, level: 19" node_number="403">Crossref</a></div><div title="valid: False, node: 404, tag: div, level: 18" node_number="404"><a title="valid: False, node: 405, tag: a, level: 19" node_number="405">PubMed</a></div><div title="valid: False, node: 406, tag: div, level: 18" node_number="406"><a title="valid: False, node: 407, tag: a, level: 19" node_number="407">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 408, tag: div, level: 14" node_number="408"><div title="valid: False, node: 409, tag: div, level: 15" node_number="409">17</div><div title="valid: False, node: 410, tag: div, level: 15" node_number="410"><div title="valid: False, node: 411, tag: div, level: 16" node_number="411"><div title="valid: False, node: 412, tag: div, level: 17" node_number="412">U. Dafni, O. Michielin, S. M. Lluesma, Z. Tsourti, V. Polydoropoulou, D. Karlis, M. J. Besser, J. Haanen, I. M. Svane, P. S. Ohashi, U. S. Kammula, A. Orcurto, S. Zimmermann, L. Trueb, C. A. Klebanoff, M. T. Lotze, L. E. Kandalaft, G. Coukos, Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: A systematic review and meta-analysis. Ann. Oncol. <b title="valid: False, node: 413, tag: b, level: 18" node_number="413">30</b>, 1902&#8211;1913 (2019).</div><div title="valid: False, node: 414, tag: div, level: 17" node_number="414"><div title="valid: False, node: 415, tag: div, level: 18" node_number="415"><a title="valid: False, node: 416, tag: a, level: 19" node_number="416">Crossref</a></div><div title="valid: False, node: 417, tag: div, level: 18" node_number="417"><a title="valid: False, node: 418, tag: a, level: 19" node_number="418">PubMed</a></div><div title="valid: False, node: 419, tag: div, level: 18" node_number="419"><a title="valid: False, node: 420, tag: a, level: 19" node_number="420">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 421, tag: div, level: 14" node_number="421"><div title="valid: False, node: 422, tag: div, level: 15" node_number="422">18</div><div title="valid: False, node: 423, tag: div, level: 15" node_number="423"><div title="valid: False, node: 424, tag: div, level: 16" node_number="424"><div title="valid: False, node: 425, tag: div, level: 17" node_number="425">Q. Zhang, M. E. Hresko, L. K. Picton, L. Su, M. J. Hollander, S. Nunez-Cruz, Z. Zhang, C.-A. Assenmacher, J. T. Sockolosky, K. C. Garcia, M. C. Milone, A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci. Transl. Med. <b title="valid: False, node: 426, tag: b, level: 18" node_number="426">625</b>, eabg6986 (2021).</div><div title="valid: False, node: 427, tag: div, level: 17" node_number="427"><div title="valid: False, node: 428, tag: div, level: 18" node_number="428"><a title="valid: False, node: 429, tag: a, level: 19" node_number="429">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 430, tag: div, level: 14" node_number="430"><div title="valid: False, node: 431, tag: div, level: 15" node_number="431">19</div><div title="valid: False, node: 432, tag: div, level: 15" node_number="432"><div title="valid: False, node: 433, tag: div, level: 16" node_number="433"><div title="valid: False, node: 434, tag: div, level: 17" node_number="434">V. Kalia, S. Sarkar, S. Subramaniam, W. N. Haining, K. A. Smith, R. Ahmed, Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity <b title="valid: False, node: 435, tag: b, level: 18" node_number="435">32</b>, 91&#8211;103 (2010).</div><div title="valid: False, node: 436, tag: div, level: 17" node_number="436"><div title="valid: False, node: 437, tag: div, level: 18" node_number="437"><a title="valid: False, node: 438, tag: a, level: 19" node_number="438">Crossref</a></div><div title="valid: False, node: 439, tag: div, level: 18" node_number="439"><a title="valid: False, node: 440, tag: a, level: 19" node_number="440">PubMed</a></div><div title="valid: False, node: 441, tag: div, level: 18" node_number="441"><a title="valid: False, node: 442, tag: a, level: 19" node_number="442">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 443, tag: div, level: 14" node_number="443"><div title="valid: False, node: 444, tag: div, level: 15" node_number="444">20</div><div title="valid: False, node: 445, tag: div, level: 15" node_number="445"><div title="valid: False, node: 446, tag: div, level: 16" node_number="446"><div title="valid: False, node: 447, tag: div, level: 17" node_number="447">Y. Liu, N. Zhou, L. Zhou, J. Wang, Y. Zhou, T. Zhang, Y. Fang, J. Deng, Y. Gao, X. Liang, J. Lv, Z. Wang, J. Xie, Y. Xue, H. Zhang, J. Ma, K. Tang, Y. Fang, F. Cheng, C. Zhang, B. Dong, Y. Zhao, P. Yuan, Q. Gao, H. Zhang, F. Xiao-Feng Qin, B. Huang, IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor. Nat. Immunol. <b title="valid: False, node: 448, tag: b, level: 18" node_number="448">22</b>, 358&#8211;369 (2021).</div><div title="valid: False, node: 449, tag: div, level: 17" node_number="449"><div title="valid: False, node: 450, tag: div, level: 18" node_number="450"><a title="valid: False, node: 451, tag: a, level: 19" node_number="451">Crossref</a></div><div title="valid: False, node: 452, tag: div, level: 18" node_number="452"><a title="valid: False, node: 453, tag: a, level: 19" node_number="453">PubMed</a></div><div title="valid: False, node: 454, tag: div, level: 18" node_number="454"><a title="valid: False, node: 455, tag: a, level: 19" node_number="455">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 456, tag: div, level: 14" node_number="456"><div title="valid: False, node: 457, tag: div, level: 15" node_number="457">21</div><div title="valid: False, node: 458, tag: div, level: 15" node_number="458"><div title="valid: False, node: 459, tag: div, level: 16" node_number="459"><div title="valid: False, node: 460, tag: div, level: 17" node_number="460">M. E. Pipkin, J. A. Sacks, F. Cruz-Guilloty, M. G. Lichtenheld, M. J. Bevan, A. Rao, Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity <b title="valid: False, node: 461, tag: b, level: 18" node_number="461">32</b>, 79&#8211;90 (2010).</div><div title="valid: False, node: 462, tag: div, level: 17" node_number="462"><div title="valid: False, node: 463, tag: div, level: 18" node_number="463"><a title="valid: False, node: 464, tag: a, level: 19" node_number="464">Crossref</a></div><div title="valid: False, node: 465, tag: div, level: 18" node_number="465"><a title="valid: False, node: 466, tag: a, level: 19" node_number="466">PubMed</a></div><div title="valid: False, node: 467, tag: div, level: 18" node_number="467"><a title="valid: False, node: 468, tag: a, level: 19" node_number="468">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 469, tag: div, level: 14" node_number="469"><div title="valid: False, node: 470, tag: div, level: 15" node_number="470">22</div><div title="valid: False, node: 471, tag: div, level: 15" node_number="471"><div title="valid: False, node: 472, tag: div, level: 16" node_number="472"><div title="valid: False, node: 473, tag: div, level: 17" node_number="473">V. Kalia, S. Sarkar, Regulation of effector and memory CD8 T cell differentiation by IL-2&#8212;A balancing act. Front. Immunol. <b title="valid: False, node: 474, tag: b, level: 18" node_number="474">9</b>, 2987 (2018).</div><div title="valid: False, node: 475, tag: div, level: 17" node_number="475"><div title="valid: False, node: 476, tag: div, level: 18" node_number="476"><a title="valid: False, node: 477, tag: a, level: 19" node_number="477">Crossref</a></div><div title="valid: False, node: 478, tag: div, level: 18" node_number="478"><a title="valid: False, node: 479, tag: a, level: 19" node_number="479">PubMed</a></div><div title="valid: False, node: 480, tag: div, level: 18" node_number="480"><a title="valid: False, node: 481, tag: a, level: 19" node_number="481">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 482, tag: div, level: 14" node_number="482"><div title="valid: False, node: 483, tag: div, level: 15" node_number="483">23</div><div title="valid: False, node: 484, tag: div, level: 15" node_number="484"><div title="valid: False, node: 485, tag: div, level: 16" node_number="485"><div title="valid: False, node: 486, tag: div, level: 17" node_number="486">T. Kaartinen, A. Luostarinen, P. Maliniemi, J. Keto, M. Arvas, H. Belt, J. Koponen, P. I. Makinen, A. Loskog, S. Mustjoki, K. Porkka, S. Yla-Herttuala, M. Korhonen, Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion. Cytotherapy <b title="valid: False, node: 487, tag: b, level: 18" node_number="487">19</b>, 689&#8211;702 (2017).</div><div title="valid: False, node: 488, tag: div, level: 17" node_number="488"><div title="valid: False, node: 489, tag: div, level: 18" node_number="489"><a title="valid: False, node: 490, tag: a, level: 19" node_number="490">Crossref</a></div><div title="valid: False, node: 491, tag: div, level: 18" node_number="491"><a title="valid: False, node: 492, tag: a, level: 19" node_number="492">PubMed</a></div><div title="valid: False, node: 493, tag: div, level: 18" node_number="493"><a title="valid: False, node: 494, tag: a, level: 19" node_number="494">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 495, tag: div, level: 14" node_number="495"><div title="valid: False, node: 496, tag: div, level: 15" node_number="496">24</div><div title="valid: False, node: 497, tag: div, level: 15" node_number="497"><div title="valid: False, node: 498, tag: div, level: 16" node_number="498"><div title="valid: False, node: 499, tag: div, level: 17" node_number="499">A. M. Ring, J. X. Lin, D. Feng, S. Mitra, M. Rickert, G. R. Bowman, V. S. Pande, P. Li, I. Moraga, R. Spolski, E. Ozkan, W. J. Leonard, K. C. Garcia, Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat. Immunol. <b title="valid: False, node: 500, tag: b, level: 18" node_number="500">13</b>, 1187&#8211;1195 (2012).</div><div title="valid: False, node: 501, tag: div, level: 17" node_number="501"><div title="valid: False, node: 502, tag: div, level: 18" node_number="502"><a title="valid: False, node: 503, tag: a, level: 19" node_number="503">Crossref</a></div><div title="valid: False, node: 504, tag: div, level: 18" node_number="504"><a title="valid: False, node: 505, tag: a, level: 19" node_number="505">PubMed</a></div><div title="valid: False, node: 506, tag: div, level: 18" node_number="506"><a title="valid: False, node: 507, tag: a, level: 19" node_number="507">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 508, tag: div, level: 14" node_number="508"><div title="valid: False, node: 509, tag: div, level: 15" node_number="509">25</div><div title="valid: False, node: 510, tag: div, level: 15" node_number="510"><div title="valid: False, node: 511, tag: div, level: 16" node_number="511"><div title="valid: False, node: 512, tag: div, level: 17" node_number="512">J. C. Yang, R. M. Sherry, S. M. Steinberg, S. L. Topalian, D. J. Schwartzentruber, P. Hwu, C. A. Seipp, L. Rogers-Freezer, K. E. Morton, D. E. White, D. J. Liewehr, M. J. Merino, S. A. Rosenberg, Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J. Clin. Oncol. <b title="valid: False, node: 513, tag: b, level: 18" node_number="513">21</b>, 3127&#8211;3132 (2003).</div><div title="valid: False, node: 514, tag: div, level: 17" node_number="514"><div title="valid: False, node: 515, tag: div, level: 18" node_number="515"><a title="valid: False, node: 516, tag: a, level: 19" node_number="516">Crossref</a></div><div title="valid: False, node: 517, tag: div, level: 18" node_number="517"><a title="valid: False, node: 518, tag: a, level: 19" node_number="518">PubMed</a></div><div title="valid: False, node: 519, tag: div, level: 18" node_number="519"><a title="valid: False, node: 520, tag: a, level: 19" node_number="520">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 521, tag: div, level: 14" node_number="521"><div title="valid: False, node: 522, tag: div, level: 15" node_number="522">26</div><div title="valid: False, node: 523, tag: div, level: 15" node_number="523"><div title="valid: False, node: 524, tag: div, level: 16" node_number="524"><div title="valid: False, node: 525, tag: div, level: 17" node_number="525">S. A. Rosenberg, M. T. Lotze, J. C. Yang, P. M. Aebersold, W. M. Linehan, C. A. Seipp, D. E. White, Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg. <b title="valid: False, node: 526, tag: b, level: 18" node_number="526">210</b>, 474&#8211;484; discussion 484&#8211;485 (1989).</div><div title="valid: False, node: 527, tag: div, level: 17" node_number="527"><div title="valid: False, node: 528, tag: div, level: 18" node_number="528"><a title="valid: False, node: 529, tag: a, level: 19" node_number="529">Crossref</a></div><div title="valid: False, node: 530, tag: div, level: 18" node_number="530"><a title="valid: False, node: 531, tag: a, level: 19" node_number="531">PubMed</a></div><div title="valid: False, node: 532, tag: div, level: 18" node_number="532"><a title="valid: False, node: 533, tag: a, level: 19" node_number="533">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 534, tag: div, level: 14" node_number="534"><div title="valid: False, node: 535, tag: div, level: 15" node_number="535">27</div><div title="valid: False, node: 536, tag: div, level: 15" node_number="536"><div title="valid: False, node: 537, tag: div, level: 16" node_number="537"><div title="valid: False, node: 538, tag: div, level: 17" node_number="538">F. L. Locke, S. S. Neelapu, N. L. Bartlett, T. Siddiqi, J. C. Chavez, C. M. Hosing, A. Ghobadi, L. E. Budde, A. Bot, J. M. Rossi, Y. Jiang, A. X. Xue, M. Elias, J. Aycock, J. Wiezorek, W. Y. Go, Phase 1 results of ZUMA-1: A multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma. Mol. Ther. <b title="valid: False, node: 539, tag: b, level: 18" node_number="539">25</b>, 285&#8211;295 (2017).</div><div title="valid: False, node: 540, tag: div, level: 17" node_number="540"><div title="valid: False, node: 541, tag: div, level: 18" node_number="541"><a title="valid: False, node: 542, tag: a, level: 19" node_number="542">Crossref</a></div><div title="valid: False, node: 543, tag: div, level: 18" node_number="543"><a title="valid: False, node: 544, tag: a, level: 19" node_number="544">PubMed</a></div><div title="valid: False, node: 545, tag: div, level: 18" node_number="545"><a title="valid: False, node: 546, tag: a, level: 19" node_number="546">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 547, tag: div, level: 14" node_number="547"><div title="valid: False, node: 548, tag: div, level: 15" node_number="548">28</div><div title="valid: False, node: 549, tag: div, level: 15" node_number="549"><div title="valid: False, node: 550, tag: div, level: 16" node_number="550"><div title="valid: False, node: 551, tag: div, level: 17" node_number="551">J. N. Kochenderfer, R. P. T. Somerville, T. Lu, V. Shi, A. Bot, J. Rossi, A. Xue, S. L. Goff, J. C. Yang, R. M. Sherry, C. A. Klebanoff, U. S. Kammula, M. Sherman, A. Perez, C. M. Yuan, T. Feldman, J. W. Friedberg, M. J. Roschewski, S. A. Feldman, L. McIntyre, M. A. Toomey, S. A. Rosenberg, Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels. J. Clin. Oncol. <b title="valid: False, node: 552, tag: b, level: 18" node_number="552">35</b>, 1803&#8211;1813 (2017).</div><div title="valid: False, node: 553, tag: div, level: 17" node_number="553"><div title="valid: False, node: 554, tag: div, level: 18" node_number="554"><a title="valid: False, node: 555, tag: a, level: 19" node_number="555">Crossref</a></div><div title="valid: False, node: 556, tag: div, level: 18" node_number="556"><a title="valid: False, node: 557, tag: a, level: 19" node_number="557">PubMed</a></div><div title="valid: False, node: 558, tag: div, level: 18" node_number="558"><a title="valid: False, node: 559, tag: a, level: 19" node_number="559">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 560, tag: div, level: 14" node_number="560"><div title="valid: False, node: 561, tag: div, level: 15" node_number="561">29</div><div title="valid: False, node: 562, tag: div, level: 15" node_number="562"><div title="valid: False, node: 563, tag: div, level: 16" node_number="563"><div title="valid: False, node: 564, tag: div, level: 17" node_number="564">N. N. Shah, T. J. Fry, Mechanisms of resistance to CAR T cell therapy. Nat. Rev. Clin. Oncol. <b title="valid: False, node: 565, tag: b, level: 18" node_number="565">16</b>, 372&#8211;385 (2019).</div><div title="valid: False, node: 566, tag: div, level: 17" node_number="566"><div title="valid: False, node: 567, tag: div, level: 18" node_number="567"><a title="valid: False, node: 568, tag: a, level: 19" node_number="568">PubMed</a></div><div title="valid: False, node: 569, tag: div, level: 18" node_number="569"><a title="valid: False, node: 570, tag: a, level: 19" node_number="570">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 571, tag: div, level: 14" node_number="571"><div title="valid: False, node: 572, tag: div, level: 15" node_number="572">30</div><div title="valid: False, node: 573, tag: div, level: 15" node_number="573"><div title="valid: False, node: 574, tag: div, level: 16" node_number="574"><div title="valid: False, node: 575, tag: div, level: 17" node_number="575">H. Yssel, H. Spits, Generation and maintenance of cloned human T cell lines. Curr. Protoc. Immunol. <b title="valid: False, node: 576, tag: b, level: 18" node_number="576">Chapter 7</b>, Unit 7.19 (2002).</div><div title="valid: False, node: 577, tag: div, level: 17" node_number="577"><div title="valid: False, node: 578, tag: div, level: 18" node_number="578"><a title="valid: False, node: 579, tag: a, level: 19" node_number="579">PubMed</a></div><div title="valid: False, node: 580, tag: div, level: 18" node_number="580"><a title="valid: False, node: 581, tag: a, level: 19" node_number="581">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 582, tag: div, level: 14" node_number="582"><div title="valid: False, node: 583, tag: div, level: 15" node_number="583">31</div><div title="valid: False, node: 584, tag: div, level: 15" node_number="584"><div title="valid: False, node: 585, tag: div, level: 16" node_number="585"><div title="valid: False, node: 586, tag: div, level: 17" node_number="586">M. J. Robertson, K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, J. Ritz, Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. <b title="valid: False, node: 587, tag: b, level: 18" node_number="587">24</b>, 406&#8211;415 (1996).</div><div title="valid: False, node: 588, tag: div, level: 17" node_number="588"><div title="valid: False, node: 589, tag: div, level: 18" node_number="589"><a title="valid: False, node: 590, tag: a, level: 19" node_number="590">PubMed</a></div><div title="valid: False, node: 591, tag: div, level: 18" node_number="591"><a title="valid: False, node: 592, tag: a, level: 19" node_number="592">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 593, tag: div, level: 14" node_number="593"><div title="valid: False, node: 594, tag: div, level: 15" node_number="594">32</div><div title="valid: False, node: 595, tag: div, level: 15" node_number="595"><div title="valid: False, node: 596, tag: div, level: 16" node_number="596"><div title="valid: False, node: 597, tag: div, level: 17" node_number="597">H. Yssel, J. E. De Vries, M. Koken, W. Van Blitterswijk, H. Spits, Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods <b title="valid: False, node: 598, tag: b, level: 18" node_number="598">72</b>, 219&#8211;227 (1984).</div><div title="valid: False, node: 599, tag: div, level: 17" node_number="599"><div title="valid: False, node: 600, tag: div, level: 18" node_number="600"><a title="valid: False, node: 601, tag: a, level: 19" node_number="601">Crossref</a></div><div title="valid: False, node: 602, tag: div, level: 18" node_number="602"><a title="valid: False, node: 603, tag: a, level: 19" node_number="603">PubMed</a></div><div title="valid: False, node: 604, tag: div, level: 18" node_number="604"><a title="valid: False, node: 605, tag: a, level: 19" node_number="605">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 606, tag: div, level: 14" node_number="606"><div title="valid: False, node: 607, tag: div, level: 15" node_number="607">33</div><div title="valid: False, node: 608, tag: div, level: 15" node_number="608"><div title="valid: False, node: 609, tag: div, level: 16" node_number="609"><div title="valid: False, node: 610, tag: div, level: 17" node_number="610">J. Charan, N. D. Kantharia, How to calculate sample size in animal studies? J. Pharmacol. Pharmacother <b title="valid: False, node: 611, tag: b, level: 18" node_number="611">4</b>, 303&#8211;306 (2013).</div><div title="valid: False, node: 612, tag: div, level: 17" node_number="612"><div title="valid: False, node: 613, tag: div, level: 18" node_number="613"><a title="valid: False, node: 614, tag: a, level: 19" node_number="614">Crossref</a></div><div title="valid: False, node: 615, tag: div, level: 18" node_number="615"><a title="valid: False, node: 616, tag: a, level: 19" node_number="616">PubMed</a></div><div title="valid: False, node: 617, tag: div, level: 18" node_number="617"><a title="valid: False, node: 618, tag: a, level: 19" node_number="618">Google Scholar</a></div></div></div></div></div></section></div></section><div class="valid" valid="valid" title="valid: True, node: 619, tag: div, level: 11" node_number="619"><div class="valid" valid="valid" title="valid: True, node: 620, tag: div, level: 12" node_number="620"><header class="valid" valid="valid" title="valid: True, node: 621, tag: header, level: 13" node_number="621"><h2 class="valid" valid="valid" title="valid: True, node: 622, tag: h2, level: 14" node_number="622">Information Authors</h2></header><section class="valid" valid="valid" title="valid: True, node: 623, tag: section, level: 13" node_number="623"><h3 class="valid" valid="valid" title="valid: True, node: 624, tag: h3, level: 14" node_number="624">Information</h3><section class="valid" valid="valid" title="valid: True, node: 625, tag: section, level: 14" node_number="625"><h4 title="valid: False, node: 626, tag: h4, level: 15" node_number="626">Published In</h4><div title="valid: False, node: 627, tag: div, level: 15" node_number="627"> <div title="valid: False, node: 628, tag: div, level: 16" node_number="628"><div title="valid: False, node: 629, tag: div, level: 17" node_number="629">Science Translational Medicine</div><div title="valid: False, node: 630, tag: div, level: 17" node_number="630">Volume 13 | Issue 625December 2021</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 631, tag: section, level: 14" node_number="631"><h4 title="valid: False, node: 632, tag: h4, level: 15" node_number="632">Copyright</h4><div title="valid: False, node: 633, tag: div, level: 15" node_number="633">Copyright &#169; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div title="valid: False, node: 634, tag: div, level: 15" node_number="634">https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div title="valid: False, node: 635, tag: div, level: 15" node_number="635">This is an article distributed under the terms of the Science Journals Default License.</div></section><section class="valid" valid="valid" title="valid: True, node: 636, tag: section, level: 14" node_number="636"><h4 title="valid: False, node: 637, tag: h4, level: 15" node_number="637">Submission history</h4><div title="valid: False, node: 638, tag: div, level: 15" node_number="638"><b title="valid: False, node: 639, tag: b, level: 16" node_number="639">Received</b>: 26 January 2021</div><div title="valid: False, node: 640, tag: div, level: 15" node_number="640"><b title="valid: False, node: 641, tag: b, level: 16" node_number="641">Accepted</b>: 16 November 2021</div></section><section class="valid" valid="valid" title="valid: True, node: 642, tag: section, level: 14" node_number="642"><h4 title="valid: False, node: 643, tag: h4, level: 15" node_number="643">Permissions</h4><div title="valid: False, node: 644, tag: div, level: 15" node_number="644">Request permissions for this article.</div><div title="valid: False, node: 645, tag: div, level: 15" node_number="645"><a title="valid: False, node: 646, tag: a, level: 16" node_number="646">Request Permissions</a></div></section><section class="valid" valid="valid" title="valid: True, node: 647, tag: section, level: 14" node_number="647"><h4 title="valid: False, node: 648, tag: h4, level: 15" node_number="648">Acknowledgments</h4><div title="valid: False, node: 649, tag: div, level: 15" node_number="649">We thank all those at Synthekine for helpful discussions and laboratory support.</div><div title="valid: False, node: 650, tag: div, level: 15" node_number="650"><b title="valid: False, node: 651, tag: b, level: 16" node_number="651">Funding:</b> The research was supported by Synthekine Inc.</div><div title="valid: False, node: 652, tag: div, level: 15" node_number="652"><b title="valid: False, node: 653, tag: b, level: 16" node_number="653">Author contributions:</b> Experiments were conceived and designed by P.-J.A., R.A.K., P.J.L., and M.O. Experiments were performed and data were analyzed by P.-J.A., S.V., M.B., M.S., N.R., R.R., R.d.W.M., D.R., J.E., and S.M. P.-J.A. and M.O. wrote the paper.</div><div title="valid: False, node: 654, tag: div, level: 15" node_number="654"><b title="valid: False, node: 655, tag: b, level: 16" node_number="655">Competing interests:</b> All authors are current employees and shareholders of Synthekine Inc.</div><div title="valid: False, node: 656, tag: div, level: 15" node_number="656"><b title="valid: False, node: 657, tag: b, level: 16" node_number="657">Data and materials availability:</b> All data associated with this study are present in the paper or the Supplementary Materials.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 658, tag: section, level: 13" node_number="658"><h3 class="valid" valid="valid" title="valid: True, node: 659, tag: h3, level: 14" node_number="659">Authors</h3><section class="valid" valid="valid" title="valid: True, node: 660, tag: section, level: 14" node_number="660"><h4 title="valid: False, node: 661, tag: h4, level: 15" node_number="661">Affiliations</h4><div title="valid: False, node: 662, tag: div, level: 15" node_number="662"><div title="valid: False, node: 663, tag: div, level: 16" node_number="663">Paul-Joseph Aspuria https://orcid.org/0000-0002-3425-846X</div><div title="valid: False, node: 664, tag: div, level: 16" node_number="664"><div title="valid: False, node: 665, tag: div, level: 17" node_number="665"><div title="valid: False, node: 666, tag: div, level: 18" node_number="666">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 667, tag: div, level: 17" node_number="667">View all articles by this author</div></div></div><div title="valid: False, node: 668, tag: div, level: 15" node_number="668"><div title="valid: False, node: 669, tag: div, level: 16" node_number="669">Sandro Vivona https://orcid.org/0000-0003-2340-3219</div><div title="valid: False, node: 670, tag: div, level: 16" node_number="670"><div title="valid: False, node: 671, tag: div, level: 17" node_number="671"><div title="valid: False, node: 672, tag: div, level: 18" node_number="672">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 673, tag: div, level: 17" node_number="673">View all articles by this author</div></div></div><div title="valid: False, node: 674, tag: div, level: 15" node_number="674"><div title="valid: False, node: 675, tag: div, level: 16" node_number="675">Michele Bauer</div><div title="valid: False, node: 676, tag: div, level: 16" node_number="676"><div title="valid: False, node: 677, tag: div, level: 17" node_number="677"><div title="valid: False, node: 678, tag: div, level: 18" node_number="678">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 679, tag: div, level: 17" node_number="679">View all articles by this author</div></div></div><div title="valid: False, node: 680, tag: div, level: 15" node_number="680"><div title="valid: False, node: 681, tag: div, level: 16" node_number="681">Marie Semana</div><div title="valid: False, node: 682, tag: div, level: 16" node_number="682"><div title="valid: False, node: 683, tag: div, level: 17" node_number="683"><div title="valid: False, node: 684, tag: div, level: 18" node_number="684">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 685, tag: div, level: 17" node_number="685">View all articles by this author</div></div></div><div title="valid: False, node: 686, tag: div, level: 15" node_number="686"><div title="valid: False, node: 687, tag: div, level: 16" node_number="687">Navneet Ratti https://orcid.org/0000-0002-5203-8989</div><div title="valid: False, node: 688, tag: div, level: 16" node_number="688"><div title="valid: False, node: 689, tag: div, level: 17" node_number="689"><div title="valid: False, node: 690, tag: div, level: 18" node_number="690">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 691, tag: div, level: 17" node_number="691">View all articles by this author</div></div></div><div title="valid: False, node: 692, tag: div, level: 15" node_number="692"><div title="valid: False, node: 693, tag: div, level: 16" node_number="693">Scott McCauley https://orcid.org/0000-0003-4549-5599</div><div title="valid: False, node: 694, tag: div, level: 16" node_number="694"><div title="valid: False, node: 695, tag: div, level: 17" node_number="695"><div title="valid: False, node: 696, tag: div, level: 18" node_number="696">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 697, tag: div, level: 17" node_number="697">View all articles by this author</div></div></div><div title="valid: False, node: 698, tag: div, level: 15" node_number="698"><div title="valid: False, node: 699, tag: div, level: 16" node_number="699">Romina Riener https://orcid.org/0000-0001-5005-112X</div><div title="valid: False, node: 700, tag: div, level: 16" node_number="700"><div title="valid: False, node: 701, tag: div, level: 17" node_number="701"><div title="valid: False, node: 702, tag: div, level: 18" node_number="702">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 703, tag: div, level: 17" node_number="703">View all articles by this author</div></div></div><div title="valid: False, node: 704, tag: div, level: 15" node_number="704"><div title="valid: False, node: 705, tag: div, level: 16" node_number="705">Rene de Waal Malefyt https://orcid.org/0000-0002-2663-383X</div><div title="valid: False, node: 706, tag: div, level: 16" node_number="706"><div title="valid: False, node: 707, tag: div, level: 17" node_number="707"><div title="valid: False, node: 708, tag: div, level: 18" node_number="708">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 709, tag: div, level: 17" node_number="709">View all articles by this author</div></div></div><div title="valid: False, node: 710, tag: div, level: 15" node_number="710"><div title="valid: False, node: 711, tag: div, level: 16" node_number="711">Deepti Rokkam</div><div title="valid: False, node: 712, tag: div, level: 16" node_number="712"><div title="valid: False, node: 713, tag: div, level: 17" node_number="713"><div title="valid: False, node: 714, tag: div, level: 18" node_number="714">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 715, tag: div, level: 17" node_number="715">View all articles by this author</div></div></div><div title="valid: False, node: 716, tag: div, level: 15" node_number="716"><div title="valid: False, node: 717, tag: div, level: 16" node_number="717">Jan Emmerich https://orcid.org/0000-0002-7216-2231</div><div title="valid: False, node: 718, tag: div, level: 16" node_number="718"><div title="valid: False, node: 719, tag: div, level: 17" node_number="719"><div title="valid: False, node: 720, tag: div, level: 18" node_number="720">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 721, tag: div, level: 17" node_number="721">View all articles by this author</div></div></div><div title="valid: False, node: 722, tag: div, level: 15" node_number="722"><div title="valid: False, node: 723, tag: div, level: 16" node_number="723">Rob A. Kastelein https://orcid.org/0000-0001-5548-4696</div><div title="valid: False, node: 724, tag: div, level: 16" node_number="724"><div title="valid: False, node: 725, tag: div, level: 17" node_number="725"><div title="valid: False, node: 726, tag: div, level: 18" node_number="726">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 727, tag: div, level: 17" node_number="727">View all articles by this author</div></div></div><div title="valid: False, node: 728, tag: div, level: 15" node_number="728"><div title="valid: False, node: 729, tag: div, level: 16" node_number="729">Patrick J. Lupardus https://orcid.org/0000-0002-8662-074X</div><div title="valid: False, node: 730, tag: div, level: 16" node_number="730"><div title="valid: False, node: 731, tag: div, level: 17" node_number="731"><div title="valid: False, node: 732, tag: div, level: 18" node_number="732">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 733, tag: div, level: 17" node_number="733">View all articles by this author</div></div></div><div title="valid: False, node: 734, tag: div, level: 15" node_number="734"><div title="valid: False, node: 735, tag: div, level: 16" node_number="735">Martin Oft<sup title="valid: False, node: 736, tag: sup, level: 17" node_number="736">*</sup> https://orcid.org/0000-0001-9833-2326 [email&#160;protected]</div><div title="valid: False, node: 737, tag: div, level: 16" node_number="737"><div title="valid: False, node: 738, tag: div, level: 17" node_number="738"><div title="valid: False, node: 739, tag: div, level: 18" node_number="739">Synthekine, Menlo Park, CA 94025, USA.</div></div><div title="valid: False, node: 740, tag: div, level: 17" node_number="740">View all articles by this author</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 741, tag: section, level: 14" node_number="741"><h4 title="valid: False, node: 742, tag: h4, level: 15" node_number="742">Notes</h4><div title="valid: False, node: 743, tag: div, level: 15" node_number="743">*Corresponding author. Email: [email&#160;protected]</div></section></section></div><div class="valid" valid="valid" title="valid: True, node: 744, tag: div, level: 12" node_number="744"><header class="valid" valid="valid" title="valid: True, node: 745, tag: header, level: 13" node_number="745"><h2 class="valid" valid="valid" title="valid: True, node: 746, tag: h2, level: 14" node_number="746">Metrics Citations</h2></header><section class="valid" valid="valid" title="valid: True, node: 747, tag: section, level: 13" node_number="747"><h3 class="valid" valid="valid" title="valid: True, node: 748, tag: h3, level: 14" node_number="748">Metrics</h3><section class="valid" valid="valid" title="valid: True, node: 749, tag: section, level: 14" node_number="749"> <h5 title="valid: False, node: 750, tag: h5, level: 15" node_number="750"> Article Usage </h5> </section><section class="valid" valid="valid" title="valid: True, node: 751, tag: section, level: 14" node_number="751"> <h5 title="valid: False, node: 752, tag: h5, level: 15" node_number="752"> Altmetrics </h5> </section></section><section class="valid" valid="valid" title="valid: True, node: 753, tag: section, level: 13" node_number="753"><h3 class="valid" valid="valid" title="valid: True, node: 754, tag: h3, level: 14" node_number="754">Citations</h3><section class="valid" valid="valid" title="valid: True, node: 755, tag: section, level: 14" node_number="755"> <div title="valid: False, node: 756, tag: div, level: 15" node_number="756"> <h5 title="valid: False, node: 757, tag: h5, level: 16" node_number="757">Export citation</h5> <p title="valid: False, node: 758, tag: p, level: 16" node_number="758">Select the format you want to export the citation of this publication.</p> </div> <div title="valid: False, node: 759, tag: div, level: 15" node_number="759"> <h5 title="valid: False, node: 760, tag: h5, level: 16" node_number="760"> Cited by </h5> <section title="valid: False, node: 761, tag: section, level: 16" node_number="761"><div title="valid: False, node: 762, tag: div, level: 17" node_number="762"><div title="valid: False, node: 763, tag: div, level: 18" node_number="763"><ol title="valid: False, node: 764, tag: ol, level: 19" node_number="764"><li title="valid: False, node: 765, tag: li, level: 20" node_number="765"><ul title="valid: False, node: 766, tag: ul, level: 21" node_number="766"><li title="valid: False, node: 767, tag: li, level: 22" node_number="767">Qian Zhang, </li><li title="valid: False, node: 768, tag: li, level: 22" node_number="768">Morgan E. Hresko, </li><li title="valid: False, node: 769, tag: li, level: 22" node_number="769">Lora K. Picton, </li><li title="valid: False, node: 770, tag: li, level: 22" node_number="770">Leon Su, </li><li title="valid: False, node: 771, tag: li, level: 22" node_number="771">Michael J. Hollander, </li><li title="valid: False, node: 772, tag: li, level: 22" node_number="772">Selene Nunez-Cruz, </li><li title="valid: False, node: 773, tag: li, level: 22" node_number="773">Zheng Zhang, </li><li title="valid: False, node: 774, tag: li, level: 22" node_number="774">Charles-Antoine Assenmacher, </li><li title="valid: False, node: 775, tag: li, level: 22" node_number="775">Jonathan T. Sockolosky, </li><li title="valid: False, node: 776, tag: li, level: 22" node_number="776">K. Christopher Garcia, </li><li title="valid: False, node: 777, tag: li, level: 22" node_number="777">Michael C. Milone, </li></ul>A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia, Science Translational Medicine, 13, 625, (2021)./doi/10.1126/scitranslmed.abg6986<div title="valid: False, node: 778, tag: div, level: 21" node_number="778">Abstract</div></li></ol></div><div title="valid: False, node: 779, tag: div, level: 18" node_number="779"><div title="valid: False, node: 780, tag: div, level: 19" node_number="780">Loading...</div></div></div></section> </div> </section></section></div><div class="valid" valid="valid" title="valid: True, node: 781, tag: div, level: 12" node_number="781"><header class="valid" valid="valid" title="valid: True, node: 782, tag: header, level: 13" node_number="782"><h2 class="valid" valid="valid" title="valid: True, node: 783, tag: h2, level: 14" node_number="783">View Options</h2></header><div class="valid" valid="valid" title="valid: True, node: 784, tag: div, level: 13" node_number="784"><h3 class="valid" valid="valid" title="valid: True, node: 785, tag: h3, level: 14" node_number="785">Get Access</h3><section class="valid" valid="valid" title="valid: True, node: 786, tag: section, level: 14" node_number="786"> <div title="valid: False, node: 787, tag: div, level: 15" node_number="787"><h5 title="valid: False, node: 788, tag: h5, level: 16" node_number="788">Log in to view the full text</h5> <p title="valid: False, node: 789, tag: p, level: 16" node_number="789"><a title="valid: False, node: 790, tag: a, level: 17" node_number="790">AAAS Log in</a></p> <p title="valid: False, node: 791, tag: p, level: 16" node_number="791">AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul title="valid: False, node: 792, tag: ul, level: 16" node_number="792"> <li title="valid: False, node: 793, tag: li, level: 17" node_number="793">Become a AAAS Member</li> <li title="valid: False, node: 794, tag: li, level: 17" node_number="794">Activate your Account</li> <li title="valid: False, node: 795, tag: li, level: 17" node_number="795"><a title="valid: False, node: 796, tag: a, level: 18" node_number="796">Purchase Access to Other Journals in the Science Family</a></li> <li title="valid: False, node: 797, tag: li, level: 17" node_number="797"><a title="valid: False, node: 798, tag: a, level: 18" node_number="798">Account Help</a></li> </ul> <div title="valid: False, node: 799, tag: div, level: 16" node_number="799"> <div title="valid: False, node: 800, tag: div, level: 17" node_number="800">Log in via OpenAthens. <div title="valid: False, node: 801, tag: div, level: 18" node_number="801"><a title="valid: False, node: 802, tag: a, level: 19" node_number="802">via OpenAthens</a></div> </div> <div title="valid: False, node: 803, tag: div, level: 17" node_number="803">Log in via Shibboleth. <div title="valid: False, node: 804, tag: div, level: 18" node_number="804"><a title="valid: False, node: 805, tag: a, level: 19" node_number="805">via Shibboleth</a></div> </div> </div> </div> <div title="valid: False, node: 806, tag: div, level: 15" node_number="806"><h4 title="valid: False, node: 807, tag: h4, level: 16" node_number="807">More options</h4><p title="valid: False, node: 808, tag: p, level: 16" node_number="808"><a title="valid: False, node: 809, tag: a, level: 17" node_number="809">Purchase digital access to this article</a></p><p title="valid: False, node: 810, tag: p, level: 16" node_number="810">Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div><div class="valid" valid="valid" title="valid: True, node: 811, tag: div, level: 13" node_number="811"><h3 class="valid" valid="valid" title="valid: True, node: 812, tag: h3, level: 14" node_number="812">View options</h3><section class="valid" valid="valid" title="valid: True, node: 813, tag: section, level: 14" node_number="813"><h4 title="valid: False, node: 814, tag: h4, level: 15" node_number="814">PDF format</h4><p title="valid: False, node: 815, tag: p, level: 15" node_number="815">Download this article as a PDF file</p><a title="valid: False, node: 816, tag: a, level: 15" node_number="816">Download PDF</a></section></div></div><div class="valid" valid="valid" title="valid: True, node: 817, tag: div, level: 12" node_number="817"><header class="valid" valid="valid" title="valid: True, node: 818, tag: header, level: 13" node_number="818"><h2 class="valid" valid="valid" title="valid: True, node: 819, tag: h2, level: 14" node_number="819">Media</h2></header><section class="valid" valid="valid" title="valid: True, node: 820, tag: section, level: 13" node_number="820"><h3 class="valid" valid="valid" title="valid: True, node: 821, tag: h3, level: 14" node_number="821">Figures</h3></section><section class="valid" valid="valid" title="valid: True, node: 822, tag: section, level: 13" node_number="822"><h3 class="valid" valid="valid" title="valid: True, node: 823, tag: h3, level: 14" node_number="823">Multimedia</h3></section></div><div class="valid" valid="valid" title="valid: True, node: 824, tag: div, level: 12" node_number="824"><header class="valid" valid="valid" title="valid: True, node: 825, tag: header, level: 13" node_number="825"><h2 class="valid" valid="valid" title="valid: True, node: 826, tag: h2, level: 14" node_number="826">Tables</h2></header></div><div class="valid" valid="valid" title="valid: True, node: 827, tag: div, level: 12" node_number="827"><header class="valid" valid="valid" title="valid: True, node: 828, tag: header, level: 13" node_number="828"><h2 class="valid" valid="valid" title="valid: True, node: 829, tag: h2, level: 14" node_number="829">Share</h2></header><h3 class="valid" valid="valid" title="valid: True, node: 830, tag: h3, level: 13" node_number="830">Share</h3><div class="valid" valid="valid" title="valid: True, node: 831, tag: div, level: 13" node_number="831"><section class="valid" valid="valid" title="valid: True, node: 832, tag: section, level: 14" node_number="832"><h4 title="valid: False, node: 833, tag: h4, level: 15" node_number="833">Share article link</h4><div title="valid: False, node: 834, tag: div, level: 15" node_number="834"><a title="valid: False, node: 835, tag: a, level: 16" node_number="835">Copy Link</a><div title="valid: False, node: 836, tag: div, level: 16" node_number="836"><p title="valid: False, node: 837, tag: p, level: 17" node_number="837">Copied!</p><p title="valid: False, node: 838, tag: p, level: 17" node_number="838">Copying failed.</p></div></div></section><section class="valid" valid="valid" title="valid: True, node: 839, tag: section, level: 14" node_number="839"><h4 title="valid: False, node: 840, tag: h4, level: 15" node_number="840">Share on social media</h4><div title="valid: False, node: 841, tag: div, level: 15" node_number="841">facebook<a title="valid: False, node: 842, tag: a, level: 16" node_number="842">twitter</a><a title="valid: False, node: 843, tag: a, level: 16" node_number="843">linkedin</a><a title="valid: False, node: 844, tag: a, level: 16" node_number="844">email</a></div></section></div></div></div></article><section class="valid" valid="valid" title="valid: True, node: 845, tag: section, level: 10" node_number="845"><div class="valid" valid="valid" title="valid: True, node: 846, tag: div, level: 11" node_number="846"><div class="valid" valid="valid" title="valid: True, node: 847, tag: div, level: 12" node_number="847"><div class="valid" valid="valid" title="valid: True, node: 848, tag: div, level: 13" node_number="848"><div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 14" node_number="849"><h3 title="valid: False, node: 850, tag: h3, level: 15" node_number="850">Submit a Response to This Article</h3></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 851, tag: div, level: 11" node_number="851"> <div class="valid" valid="valid" title="valid: True, node: 852, tag: div, level: 12" node_number="852"> <h2 class="valid" valid="valid" title="valid: True, node: 853, tag: h2, level: 13" node_number="853">(0)eLetters</h2> </div> <p class="valid" valid="valid" title="valid: True, node: 854, tag: p, level: 12" node_number="854">eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> <a class="valid" valid="valid" title="valid: True, node: 855, tag: a, level: 12" node_number="855">Log In to Submit a Response</a> <p class="valid" valid="valid" title="valid: True, node: 856, tag: p, level: 12" node_number="856">No eLetters have been published for this article yet.</p> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 857, tag: div, level: 10" node_number="857"><a class="valid" valid="valid" title="valid: True, node: 858, tag: a, level: 11" node_number="858">View Full Text</a><a class="valid" valid="valid" title="valid: True, node: 859, tag: a, level: 11" node_number="859">Download PDF</a></div> </div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 860, tag: div, level: 6" node_number="860"><div class="valid" valid="valid" title="valid: True, node: 861, tag: div, level: 7" node_number="861"><div class="valid" valid="valid" title="valid: True, node: 862, tag: div, level: 8" node_number="862"><div class="valid" valid="valid" title="valid: True, node: 863, tag: div, level: 9" node_number="863"><section class="valid" valid="valid" title="valid: True, node: 864, tag: section, level: 10" node_number="864"><div class="valid" valid="valid" title="valid: True, node: 865, tag: div, level: 11" node_number="865"><h4 class="valid" valid="valid" title="valid: True, node: 866, tag: h4, level: 12" node_number="866"> Current Issue </h4><div class="valid" valid="valid" title="valid: True, node: 867, tag: div, level: 12" node_number="867"><div class="valid" valid="valid" title="valid: True, node: 868, tag: div, level: 13" node_number="868"> <div class="valid" valid="valid" title="valid: True, node: 869, tag: div, level: 14" node_number="869"><div title="valid: False, node: 870, tag: div, level: 15" node_number="870"><article title="valid: False, node: 871, tag: article, level: 16" node_number="871"><div title="valid: False, node: 872, tag: div, level: 17" node_number="872"><div title="valid: False, node: 873, tag: div, level: 18" node_number="873"><h3 title="valid: False, node: 874, tag: h3, level: 19" node_number="874"><a title="valid: False, node: 875, tag: a, level: 20" node_number="875">Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul title="valid: False, node: 876, tag: ul, level: 19" node_number="876"><li title="valid: False, node: 877, tag: li, level: 20" node_number="877">By<ul title="valid: False, node: 878, tag: ul, level: 21" node_number="878"> <li title="valid: False, node: 879, tag: li, level: 22" node_number="879">Jay-Hyun Jo</li> <li title="valid: False, node: 880, tag: li, level: 22" node_number="880">Catriona P. Harkins</li> <li title="valid: False, node: 881, tag: li, level: 22" node_number="881">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 882, tag: article, level: 16" node_number="882"><div title="valid: False, node: 883, tag: div, level: 17" node_number="883"><div title="valid: False, node: 884, tag: div, level: 18" node_number="884"><h3 title="valid: False, node: 885, tag: h3, level: 19" node_number="885">A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul title="valid: False, node: 886, tag: ul, level: 19" node_number="886"><li title="valid: False, node: 887, tag: li, level: 20" node_number="887">By<ul title="valid: False, node: 888, tag: ul, level: 21" node_number="888"> <li title="valid: False, node: 889, tag: li, level: 22" node_number="889">Qian Zhang</li> <li title="valid: False, node: 890, tag: li, level: 22" node_number="890">Morgan E. Hresko</li> <li title="valid: False, node: 891, tag: li, level: 22" node_number="891">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 892, tag: article, level: 16" node_number="892"><div title="valid: False, node: 893, tag: div, level: 17" node_number="893"><div title="valid: False, node: 894, tag: div, level: 18" node_number="894"><h3 title="valid: False, node: 895, tag: h3, level: 19" node_number="895">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul title="valid: False, node: 896, tag: ul, level: 19" node_number="896"><li title="valid: False, node: 897, tag: li, level: 20" node_number="897">By<ul title="valid: False, node: 898, tag: ul, level: 21" node_number="898"> <li title="valid: False, node: 899, tag: li, level: 22" node_number="899">Paul-Joseph Aspuria</li> <li title="valid: False, node: 900, tag: li, level: 22" node_number="900">Sandro Vivona</li> <li title="valid: False, node: 901, tag: li, level: 22" node_number="901">et al.</li> </ul> </li></ul></div></div></article></div><div title="valid: False, node: 902, tag: div, level: 15" node_number="902"><a title="valid: False, node: 903, tag: a, level: 16" node_number="903">Table of Contents</a></div></div> </div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 904, tag: section, level: 10" node_number="904"> <h4 class="valid" valid="valid" title="valid: True, node: 905, tag: h4, level: 11" node_number="905">LATEST NEWS</h4> <div class="valid" valid="valid" title="valid: True, node: 906, tag: div, level: 11" node_number="906"> <div class="valid" valid="valid" title="valid: True, node: 907, tag: div, level: 12" node_number="907"><div class="valid" valid="valid" title="valid: True, node: 908, tag: div, level: 13" node_number="908"> <article class="valid" valid="valid" title="valid: True, node: 909, tag: article, level: 14" node_number="909"> <div title="valid: False, node: 910, tag: div, level: 15" node_number="910"> <div title="valid: False, node: 911, tag: div, level: 16" node_number="911"> News<time title="valid: False, node: 912, tag: time, level: 17" node_number="912">30 Dec 2021</time> </div> <div title="valid: False, node: 913, tag: div, level: 16" node_number="913"> Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 914, tag: article, level: 14" node_number="914"> <div title="valid: False, node: 915, tag: div, level: 15" node_number="915"> <div title="valid: False, node: 916, tag: div, level: 16" node_number="916"> ScienceInsider<time title="valid: False, node: 917, tag: time, level: 17" node_number="917">29 Dec 2021</time> </div> <div title="valid: False, node: 918, tag: div, level: 16" node_number="918"> Once a &#8216;crazy idea,&#8217; patent-pooling nonprofit will help bring COVID-19 pills to world&#8217;s poor </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 919, tag: article, level: 14" node_number="919"> <div title="valid: False, node: 920, tag: div, level: 15" node_number="920"> <div title="valid: False, node: 921, tag: div, level: 16" node_number="921"> ScienceInsider<time title="valid: False, node: 922, tag: time, level: 17" node_number="922">28 Dec 2021</time> </div> <div title="valid: False, node: 923, tag: div, level: 16" node_number="923"> The natural world loses two of its biggest advocates </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 924, tag: article, level: 14" node_number="924"> <div title="valid: False, node: 925, tag: div, level: 15" node_number="925"> <div title="valid: False, node: 926, tag: div, level: 16" node_number="926"> ScienceInsider<time title="valid: False, node: 927, tag: time, level: 17" node_number="927">28 Dec 2021</time> </div> <div title="valid: False, node: 928, tag: div, level: 16" node_number="928"> <a title="valid: False, node: 929, tag: a, level: 17" node_number="929"> What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 930, tag: article, level: 14" node_number="930"> <div title="valid: False, node: 931, tag: div, level: 15" node_number="931"> <div title="valid: False, node: 932, tag: div, level: 16" node_number="932"> ScienceInsider<time title="valid: False, node: 933, tag: time, level: 17" node_number="933">25 Dec 2021</time> </div> <div title="valid: False, node: 934, tag: div, level: 16" node_number="934"> NASA&#8217;s Webb telescope takes flight&#8212;a Christmas gift to astronomers everywhere </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 935, tag: article, level: 14" node_number="935"> <div title="valid: False, node: 936, tag: div, level: 15" node_number="936"> <div title="valid: False, node: 937, tag: div, level: 16" node_number="937"> News<time title="valid: False, node: 938, tag: time, level: 17" node_number="938">23 Dec 2021</time> </div> <div title="valid: False, node: 939, tag: div, level: 16" node_number="939"> <a title="valid: False, node: 940, tag: a, level: 17" node_number="940"> More than a virus: Science&#8217;s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>